GRANTS DATABASE- DECEMBER 2007
Dept
ANESTHESIOLOGY & PAIN MEDICINE
ANESTHESIOLOGY & PAIN MEDICINE
ANESTHESIOLOGY & PAIN MEDICINE
ANESTHESIOLOGY & PAIN MEDICINE
ANESTHESIOLOGY & PAIN MEDICINE
ANESTHESIOLOGY & PAIN MEDICINE
ANESTHESIOLOGY & PAIN MEDICINE
ANESTHESIOLOGY & PAIN MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
BIOCHEMISTRY & MOLECULAR MEDICINE
PI Name
ANTOGNINI, JOSEPH
Title
BRAIN AND SPINAL CORD CONTRIBUTIONS
TO ANESTHETIC ACTION
ANTOGNINI, JOSEPH
ANESTHETIC EFFECTS ON NOCICEPTIVE
PROCESSING
ANTOGNINI, JOSEPH
ANESTHETIC EFFECTS ON SENSORIMOTOR
INTEGRATION
IMPACT OF DRUG CONTROL POLICY ON PAIN
FISHMAN, SCOTT
TREATMENT IN CALIFORNIA: ARE
PHYSICIANS UNWILLING TO PRESCRIBE
NEEDED MEDICATION?
JINKS, STEVEN
VOLATILE ANESTHETIC ACTION IN
VERTEBRATE LOCOMOTOR SYSTEMS
KALAUOKALANI, DONNACHRONIC PAIN MANAGEMENT PROG
LIN, YU-FUNG
MODULATION OF POTASSIUM CHANNELS BY
NITRIC OXIDE AND NEUROPROTECTION
SMITH, ANNE
DYNAMIC ANALYSES OF LEARNING IN
BEHAVIORAL EXPERIMENTS
CARRAWAY, KERMIT
MODULATION OF ERBB RECEPTOR
TYROSINE KINASE SIGNALING
CARRAWAY, KERMIT
MODULATION OF ERBB RECEPTOR
TYROSINE KINASE SIGNALING
CARRAWAY, KERMIT
NRDP1 PROTEIN DEGRADATION PATHWAY
IN MAMMARY TUMOR PROGRESSION
CHEN, HONGWU
PROTEIN ACETYLATION AS MECHANISM OF
HORMONE SIGNALING
CHEN, HONGWU
ROLE OF COACTIVATORS IN CELL GROWTH
AND TUMORIGENESIS
HAGERMAN, PAUL
PATHOGENESIS OF FXTAS
HAGERMAN, PAUL
EXPRESSION OF THE FRAGILE X GENE
HAGERMAN, PAUL
FRAGILE X-ASSOCIATED TREMOR/ ATAXIA
SYNDROME
HAGERMAN, PAUL
DEVELOPMENT OF TARGETED THERAPEUTIC
AGENTS FOR THE TREATMENT OF FXTAS
(HAGERMAN 2 OF 6)
HAGERMAN, PAUL
NEURO THERAPEUTICS RES INST
(HAGERMAN 1 OF 6)
HERSHEY, JOHN
PROG IN VIRUS TRANSLATIONAL CONTROL
KUNG, HSING-JIEN
ONCOGENIC PATHWAYS OF MAREK'S
DISEASE VIRUS
KUNG, HSING-JIEN
tyrosine kinases and prostate growth
KUNG, HSING-JIEN
MODELING ANDROGEN RECEPTOR IN
BIOCHEMISTRY & MOLECULAR MEDICINE
MILLER, JAMIE
BIOCHEMISTRY & MOLECULAR MEDICINE
SELDIN, MICHAEL
BIOCHEMISTRY & MOLECULAR MEDICINE
SELDIN, MICHAEL
BIOCHEMISTRY & MOLECULAR MEDICINE
SELDIN, MICHAEL
BIOCHEMISTRY & MOLECULAR MEDICINE
SELDIN, MICHAEL
BIOCHEMISTRY & MOLECULAR MEDICINE
SWEENEY, COLLEEN
BIOCHEMISTRY & MOLECULAR MEDICINE
VOSS, JOHN
CELL BIOLOGY & HUMAN ANATOMY
CHAN, CAMIE
CELL BIOLOGY & HUMAN ANATOMY
DENG, WENBIN
CELL BIOLOGY & HUMAN ANATOMY
DENG, WENBIN
CELL BIOLOGY & HUMAN ANATOMY
CELL BIOLOGY & HUMAN ANATOMY
DENG, WENBIN
DENG, WENBIN
CELL BIOLOGY & HUMAN ANATOMY
DENG, WENBIN
CELL BIOLOGY & HUMAN ANATOMY
DOUGLAS, GORDON
CELL BIOLOGY & HUMAN ANATOMY
DOUGLAS, GORDON
CELL BIOLOGY & HUMAN ANATOMY
ERICKSON, KENT
CELL BIOLOGY & HUMAN ANATOMY
FITZGERALD, PAUL
CELL BIOLOGY & HUMAN ANATOMY
FITZGERALD, PAUL
CELL BIOLOGY & HUMAN ANATOMY
GONG, QIZHI
INVOLVEMENT OF THE NOVEL ERBB
NEGATIVE REGULATOR LRIG1 IN BREAST
ANCESTRY ASSOCIATION ANALYSES OF WHI
TRAITS
MA ADMIXTURE MAPPING DEVELOPMENT
AND APPLICATION TO NIDDM
ADMIXTURE MAPPING DEVELOPMENT AND
TESTING IN AA SLE
THE INTERPLAY OF DEMOGRAPHIC,
SOCIOECONOMIC AND GENETIC FACTORS
IN SLE OUTCOMES
MECHANISMS OF RECEPTOR TYROSINE
KINASE INHIBITION
THE STRUCTURAL BASIS OF APOE4’S ROLE
IN ALZHEIMER’S DISEASE
USING HUMANIZED MICE TO IDENTIFY THE
HUMAN COUNTERPART OF INTERFERON
PRODUCING KILLER DENDRITIC CELLS
(IKDCS) INVOLVED IN TUMOR
IMMUNOSURVEILLANCE: DEVELOPMENT OF
EFFECTIVE IMMUNOTHERAPIES FOR
MECHANISMS OF MICROGLIAL ACTIVATION
UNDERLYING EAE
MECHANISMS OF MICROGLIAL ACTIVATION
UNDERLYING THE BRAIN INJURY IN
PREMATURE INFANTS
OLIGODENDROGLIA AND LEAD
ES CELL DERIVED HUMAN OLIGODENROGLIA
FOR ASSESSMENT OF NEUROTOXICITY IN
VITRO
OLIGODENDROCYTES, GLUTAMATE
RECEPTORS AND LEAD NEUROTOXICITY
FLOW EFFECTS ON ENDOTHELIAL/
TROPHOBLAST INTERACTION
REGULATION OF TROPHOBLAST STEM CELL
DIFFERENTIATION
ABLATION OF NORMAL MAMMARY AND
TUMOR STEM CELLS AS MEANS FOR
DECREASING BREAST CANCER RISK
SDSL-EPR STUDY OF INTERMEDIATE
FILAMENT STRUCTURE
MOLECULAR ANALYSIS OF OCULAR LENS
BEADED FILAMENTS
DEVELOPMENT OF THE OLFACTORY
CONNECTIONS
CELL BIOLOGY & HUMAN ANATOMY
DEAN'S OFFICE
DEAN'S OFFICE
DEAN'S OFFICE
DEAN'S OFFICE
DEAN'S OFFICE
DEAN'S OFFICE
DEAN'S OFFICE
DEAN'S OFFICE
DEAN'S OFFICE
DEAN'S OFFICE
DERMATOLOGY
DERMATOLOGY
DERMATOLOGY
DERMATOLOGY
DERMATOLOGY
DERMATOLOGY
DERMATOLOGY
DERMATOLOGY
EMERGENCY MEDICINE
EMERGENCY MEDICINE
EMERGENCY MEDICINE
EMERGENCY MEDICINE
ZHOU, CHENGJI
THE ROLE OF WNT SIGNALING IN
OLIGODENDROCYTE LINEAGE
BERGLUND, LARS
UC DAVIS CLINICAL AND TRANSLATIONAL
SCIENCE CTR
BONHAM, ANN
INTEGRATING MEDICINE INTO BASIC
SCIENCE AT UC DAVIS
NESBITT, THOMAS
IMPROVING SELF CARE BEHAVIOR AND
OUTCOMES IN RURAL PATIENTS WITH
HEART FAILURE
POMEROY, CLAIRE
BUILDING INTERDISCIPLINARY CAREERS IN
WOMEN’S HEALTH AT UC DAVIS
BERA, AMERISH
IMANI CLINIC HEALTHY BREAST PROG
BERA, AMERISH
CONSORTIUM OF STUDENT RUN CLINICS
HEALTHY BREAST PROG
BERA, AMERISH
SHIFA CLINIC HEALTHY BREAST PROG
BERA, AMERISH
VN CARES HEALTHY BREAST PROG
CALIF POSTBACCALAUREATE CONSORTIUM BERA, AMERISH
PHASE II
WILKES, MICHAEL
CULTURAL COMPETENCE IN MEDICAL
STUDENT EDUC: AN INTEGRATED AND
DEVELOPMENTALLY INFORMED CURRICULUM
keratinocyte galvanotaxis and wound healing
ISSEROFF, RIVKAH
ISSEROFF, RIVKAH
BETA ADRENERGIC RECEPTOR MODULATION
OF BURN WOUND HEALING
LEE, CHAI SUE
A DOUBLE BLIND, RANDOMIZED, PLACEBO
CONTROLLED, SEQUENTIAL COHORT
EXPLORATORY STUDY OF THE SAFETY AND
EFFICACY OF JNJ-26113100 IN THE
TREATMENT OF ADULT ATOPHIC
DERMATITIS THAT IS MODERATE IN
LIU, FU-TONG
REGULATION OF SKIN WOUND
EPITHELIALIZATION BY GALECTIN-3
LIU, FU-TONG
MOLECULAR AND CELLULAR
CHARACTERIZATION OF SPONGIOTIC
DERMATITIS
LIU, FU-TONG
GALECTINS AND INNATE IMMUNITY
MAVERAKIS, EMANUAL GC399TR AN INHIBITOR OF AUTOIMMUNITY
TAKADA, YOSHIKAZU INTEGRINS AND PRO-INFLAMMATORY
SECRETORY PHOSPHOLIPASE A2
DERLET, ROBERT
SACRAMENTO EFFECTIVE MEDICAL CARE
DIERCKS, DEBORAH
PRO-BNP FOR DIAGNOSIS AND PROGNOSIS
IN PATIENTS PRESENTING WITH DYSPNEA
EMERGENCY MED PULMONARY EMBOLISM IN
DIERCKS, DEBORAH
THE REAL WORLD REGISTRY (EMPEROR)
DIERCKS, DEBORAH
NATRIURETIC PEPTIDES AND NOVEL
EMERGENCY MEDICINE
EMERGENCY MEDICINE
EMERGENCY MEDICINE
EMERGENCY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
FAMILY & COMMUNITY MEDICINE
INTERNAL MEDICINE
KUPPERMANN, NATHAN PREDICTING CERVICAL SPINE INJURY IN
CHILDREN
PANACEK, EDWARD
A PHASE II, MULTICENTER, RANDOMIZED,
DOUBLE MASK, DOUBLE DUMMY STUDY
COMPARING THE EFFICACY AND SAFETY OF
PERAMIVIR ADMINISTERED ONCE DAILY
VERSUS OSELTAMIVIR ADMINISTERED
ORALLY TWICE DAILY IN ADULTS WITH
ACUTE SERIOUS OR POTENTIALLY LIFE
THREATENING INFLUENZA
WINTEMUTE, GAREN
FIREARMS DOMESTIC VIOLENCE EDUC AND
INTERVENTIONS PROJ
WINTEMUTE, GAREN
INITIATIVES IN GUN VIOLENCE PREVENTION
BALSBAUGH, THOMAS 2004 SONG BROWN RESIDENCY PROG CAPITATION APPLICATION
BALSBAUGH, THOMAS 2005 SONG BROWN FAMILY RESIDENCY
PROG - CAPITATION APPLICATION
BALSBAUGH, THOMAS 2006 SONG BROWN FAMILY RESIDENCY
PROG - CAPITATION APPLICATION
FENTON, JOSHUA
AMERICAN CANCER SOCIETY MENTORED
RES SCHOLAR
FENTON, JOSHUA
CHARACTERIZING EFFECTIVE COUNSELING
REGARDING COLORECTAL CANCER
FRANKS, PETER
USING SOCIAL RISK TO GUIDE
CHOLESTEROL TREATMENT
INGELL, BETTY
SONG BROWN PRIMARY CARE PHYSICAN
ASSISTANT AND FAMILY NURSE
PRACTITIONER TRAINING PROG
INGELL, BETTY
PHYSICIAN ASSISTANT TRAINING IN
PRIMARY CARE
JERANT, ANTHONY
a randomized trial of home self-efficacy
enhancement
MELNIKOW, JOY
surveillance strategies following treatment
for cervical INTRAEPITHELIAL NEOPLASIA
NELSEN, KAY
CALIF ACADEMIC CHRONIC CARE
COLLABORATIVE
NESBITT, THOMAS
PHARMACY CONSULTATION FOR RURAL
HOSPITALS
AMSTERDAM, EZRA
LUNAR: A 12 WEEK, RANDOMIZED, OPEN
LABEL, 3 ARM, PARALLEL GROUP,
MULTICENTER, PHASE IIIB STUDY
COMPARING THE EFFICACY AND SAFETY OF
ROSUVASTATIN 20MG AND 40MG WITH
THAT OF ATORVASTATIN 80MG IN SUBJECTS
WITH ACUTE CORONARY SYNDROMES
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL
INTERNAL
INTERNAL
INTERNAL
MEDICINE
MEDICINE
MEDICINE
MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
CHIAMVIMONVAT, NIPAVFUNCTIONS OF CALCIUM ACTIVITATED ION
CHANNELS IN THE HEART
GLATTER, KATHRYN
does af suppression pacing promote reverse
electrical remodeling of the atria? (01-08HAGIWARA, NOBUKO THE ROLE OF SOX6 IN POSTNATAL
MATURATION OF THE HEART
HAGIWARA, NOBUKO THE ROLE OF SOX6 IN MUSCLE
KNOWLTON, ANNE
HSP60, APOPTOSIS AND MYOCARDIAL
KNOWLTON, ANNE
HUMAN CARDIOMYOPATHY AND HSP60
KNOWLTON, ANNE
HSPS, INFLAMMATORY RESPONSE AND
CARDIOVASCULAR DISEASE
LAIRD, JOHN
ASSESSMENT OF CHEST PAIN IN THE
EMERGENCY DEPT USING ENDO-PAT
LAIRD, JOHN
SAPPHIRE - STENTING AND ANGIOPLASTY
WITH PROTECTION IN PATIENTS AT HIGH
RISK FOR ENDARTERECTOMY
LAIRD, JOHN
ATRIUM ICAST LLIAC STENT PIVOTAL STUDY
LAIRD, JOHN
EVALUATING THE USE OF THE FIBERNET
EMBOLIC PROTECTION SYSTEM IN CAROTID
ARTERY STENTING: THE EPIC US PIVOTAL
STUDY
LOW, REGINALD
TAXUS IV-SR: TREATMENT OF DE NOVO
CORONARY DISEASE USING A SINGLE
PACLITAXEL-ELUTING STENT
LOW, REGINALD
GREAT: GUIDED RADIO FREQUENCY
ENERGY ABLATION OF TOTAL OCCLUSIONS
LOW, REGINALD
INTRAVASCULAR COOLING ADJUNCTIVE TO
PERCUTANEOUS CORONARY INTERVENTION
(ICE-IT)
LOW, REGINALD
TAXUS V: A RANDOMIZED, DOUBLE BLIND
TRIAL TO ASSESS TAXUS PACLITAXELELUTING CORONARY STENTS, SLOWRELEASE FORMULATION
LOW, REGINALD
A MULTICENTER, RANDOMIZED, DOUBLE
BLIND, PLACEBO CONTROLLED STUDY TO
EVALUATE THE EFFICACY AND SAFETY OF
AD5FGF-4 IN PATIENTS WITH STABLE
LOW, REGINALD
ARRIVE TAXUS PERI-APPROVAL REGISTRY:
A TWO PHASED, MULTICENTER SAFETY
SURVEILLANCE PROG
LOW, REGINALD
FACTOR: FLOWCARDIA’S APPROACH TO
CHRONIC TOTAL OCCLUSION
RECANALIZATION: CLINICAL
INVESTIGATIONAL PLAN
LOW, REGINALD
WATCHMAN LEFT ATRIAL APPENDAGE
INTERNAL MEDICINE
LOW, REGINALD
INTERNAL MEDICINE
LOW, REGINALD
INTERNAL MEDICINE
LOW, REGINALD
INTERNAL MEDICINE
LOW, REGINALD
INTERNAL MEDICINE
ROGERS, JASON
INTERNAL MEDICINE
SCHAEFER, SAUL
INTERNAL MEDICINE
SRIVATSA, UMA
INTERNAL MEDICINE
SRIVATSA, UMA
INTERNAL MEDICINE
SRIVATSA, UMA
INTERNAL MEDICINE
VALENTE, RICHARD
INTERNAL MEDICINE
VALENTE, RICHARD
ENDEAVOR IV: A RANDOMIZED,
CONTROLLED TRIAL OF THE MEDTRONIC
ENDEAVOR DRUG (ABT-578) ELUTING
CORONARY STENT SYSTEM VERSUS THE
TAXUS PACLITAXEL ELUTING CORONARY
STENT SYSTEM IN DE NOVO NATIVE
A PHASE I-II, MULTICENTER, RANDOMIZED,
DOUBLE BLIND, PLACEBO CONTROLLED,
PROSPECTIVE STUDY TO EVALUATE THE
SAFETY AND POTENTIAL EFFICACY OF
SINGLE, INCREASING DOSES OF TG100-115
IN SUBJECTS UNDERGOING PERCUTANEOUS
CORONARY INTERVENTION FOR ACUTE ST
ELEVATION MYOCARDIAL INFARCTION
THE CHAMPION PCI TRIAL: A CLINICAL
TRIAL COMPARING CANGRELOR TO
CLOPIDOGRELOR TO CLOPIDOGREL IN
SUBJECTS WHO REQUIRE PERCUTANEOUS
TAXUS PERSEUS: A PROSPECTIVE EVAL IN
A RANDOMIZED TRIAL OF THE SAFETY AND
EFFICACY OFTHE USE OF TAXUS ELEMENT
OF THE PACLITAXEL ELUDING CORONARY
STENT SYSTEM FOR THE TREATMENT OF DE
NOVO CORONARY ARTERY LESIONS
ECLIPSE STUDY (ENSURE’S VASCULAR
CLOSURE DEVICE SPEEDS HEMOSTASIS
STUDY)
PBR MODULATES MITOCHONDRIAL CALCIUM
ENTRY THROUGH VDAC
RESPONSE HF: RESPONSE OF CARDIAC
RESYNCHRONIZATION THERAPY
OPTIMIZATION WITH V-V TIMING IN HEART
FAILURE PATIENTS
VENTRICULAR RATE REGULARIZATION FOR
IMPROVED RESPONSE TO CARDIAC
RESYNCHRONIZATION THERAPY IN
PATIENTS WITH ATRIAL FIBRILLATION
STOP AF: A RANDOMIZED, CONTROLLED
CLINICAL TRIAL OF CATHETER
CRYOABLATION IN THE TREATMENT OF
PAROXYSMAL ATRIAL FIBRILLATION
PLUS PERFUSION BY THROMBOLYTIC AND
ULTRASOUND
H7T-MC-TAAL: A COMPARISON OF CS-747
AND CLOPIDOGREL IN ACUTE CORONARY
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
WANG, SAMUEL
BIOTRONIK HOME MONITORING
TECHNOLOGY FOR IMPLANTABLE
CARDiOVERTER DEFIBRILLATOR THERAPY
WIRELESS, AUTOMATIC, MOBILE
WANG, SAMUEL
ARRHYTHMIA SINGLE SHOCK DFT VERSUS
ULV: RISK REDUCTION EVAL WITH ICD
IMPLANTATIONS (ASSURE)
WHITCOMB, CHARLES THE APPROACH STUDY: A PHASE III,
MULTICENTER, DOUBLE BLIND, CLINICAL
TRIAL TO COMPARE ROSIGLITAZONE
VERSUS GLIPIZIDE ON THE PROGRESSION
OF ATHEROSCLEROSIS IN SUBJECTS WITH
TYPE 2 DIABETES MELLITUS AND
CARDIOVASCULAR DISEASE
HALSTED, CHARLES
SAME AND FOLATE DEFICIENCY IN
ALCOHOLIC MICROPIGS
HALSTED, CHARLES
EFFECTS OF SAM IN PATIENTS WITH
ALCOHOLIC LIVER DISEASE
HAMANN, KENDAL
BONE MINERAL DENSITY AMONG
HYPOGONADAL MEN WITH HIV
HUSER, THOMAS
MRI DEVELOPMENT OF OMX: A
STRUCTURED ILLUMINATION MICROSCOPE
SYSTEM WITH SUB-100 NM SPATIAL
RESOLUTION FOR APPLICATIONS IN CELL
KASIM-KARAKAS, SIDIKPREVENTION OF POST-PRANDIAL
HYPOGLYCEMIA USING N-3/N-6 PUFA IN
KASIM-KARAKAS, SIDIKFBCX AND BODY WEIGHT REGULATION IN
OVERNIGHT HUMANS
KASIM-KARAKAS, SIDIKWALNUTS VS. WALNUT OIL, GLUCOSE
HOMEOSTASIS IN PCOS
LEE, JENNIFER
ENDOGENOUS ESTRADIOL AND EFFECTS OF
ESTROGEN THERAPY ON MAJOR OUTCOMES
OF WHI
LEE, JENNIFER
ENDOGENOUS SEX HORMONES AND
GENETIC RISK FACTORS FOR STROKE
LEE, JENNIFER
WHI SEX HORMONES AND GENETIC RISK
FACTORS FOR HIP FRACTURES
MUKHERJEA, RATNA
EFFECT OF WALNUT CONSUMPTION DURING
PREGNANCY AND LACTATION ON RISK
FACTORS FOR GLUCOSE INTOLERANCE,
CARDIOVASCULAR DISEASE AND BREAST
MILK CONSUMPTION
RUTLEDGE, JOHN
VISITING PROFESSORSHIP
RUTLEDGE, JOHN
IMAGING LIPOPROTEIN ENDOTHELIAL CELL
INTERACTIONS
INTERNAL MEDICINE
ROSSARO, LORENZO
INTERNAL MEDICINE
ROSSARO, LORENZO
INTERNAL MEDICINE
ROSSARO, LORENZO
INTERNAL MEDICINE
ROSSARO, LORENZO
INTERNAL MEDICINE
ROSSARO, LORENZO
INTERNAL MEDICINE
ROSSARO, LORENZO
INTERNAL MEDICINE
ROSSARO, LORENZO
COMPARISON OF PEG-INTRON 1.5
UG/KG/WK PLUS REBETOL VS. PEG-INTRON
1UG/KG/WK PLUS REBETOL VS. PEGASYS
180 UG/KG/WK PLUS COPEGUS IN
PREVIOUSLY UNTREATED ADULT SUBJECTS
WITH CHRONIC HEPATITIS C INFECTED
A PROSPECTIVE MULTICENTER, OPEN LABEL,
COMPARATIVE EFFICACY STUDY OF
PEGASYS PLUS COPEGUS IN TREATMENT OF
NAIVE LATINO PATIENTS WITH CHRONIC
HEPATITIS C - GENETYPE 1, AS COMPARED
TO TREATMENT NAIVE NON LATINO
CAUCASIAN PATIENTS WITH CHRONIC
A MULTICENTER, RANDOMIZED, DOUBLE
BLIND, PLACEBO CONTROLLED TRIAL TO
EVALUATE THE EFFICACY, SAFETY AND
TOLERABILITY OF RIFAXIMIN 550 MG BID
FOR 6 MONTHS IN PREVENTNG HEPATIC
ENCEPHALOPATHY (RFHE3001)
PHASE II, RANDOMIZED, MULTICENTER,
DOUBLE BLINDED STUDY EVALUATING THE
SAFETY AND TOLERABILITY OF THE HCV
POLYMERASE INHIBITOR PRODRUG
(RO4588161) WHEN GIVEN IN
COMBINATION WITH PEGASYS WITH OR
WITHOUT COPEGUS VERSUS THE
CURRENTLY APPROVED COMBINATION OF
PEGASYS AND COPEGUS IN TREATMENT
NAIVE PATIENTS WITH CHRONIC HEPATITIS
PHASE IV, RANDOMIZED, MULTICENTER,
DOUBLE BLIND, STUDY EVALUATING THE
EFFICACY (AS MEASURED BY SUSTAINED
VIROLOGICAL RESPONSE) AND SAFETY OF
360 UG INDUCTION DOSING OF PEGASYS IN
COMBINATION WITH HIGH COPEGUS DOSES
IN TREATMENT OF NAIVE PATIENTS WITH
CHRONIC HEPATITIS C GENOTYPE 1 VIRUS
INFECTION OF HIGH VIRAL TITER AND
BASELINE BODY WEIGHT GREATER THAN OR
EQUAL TO 85 KG
A SAFETY AND EFFICACY STUDY OF SCH
503034 IN PREVIOUSLY UNTREATED
SUBJECTS WITH CHRONIC HEPATITIS C
INFECTED WITH GENOTYPE 1
A MULTICENTER, OPEN LABEL TRIAL TO
EVALUATE THE LONG TERM SAFETY AND
TOLERABILITY OF RIFAXIMIN 550 MG BID IN
SUBJECTS WITH A HISTORY OF HEPATIC
ENCEPHALOPATHY
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
ROSSARO, LORENZO
A PHASE II, RANDOMIZED, DOUBLE
BLINDED, MULTICENTER, DOSE FINDING
STUDY EVALUATING THE EFFICACY AND
SAFETY OF THE HCV POLYERASE INHIBITOR
PRODRUG (R04588161) WHEN GIVEN IN
COMBINATION WITH PEGASYS AND
COPEGUS VERSUS THE CURRENTLY
APPROVED COMBINATION OF PEGASYS AND
COPEGUS IN TREATMENT NAIVE PATIENTS
WITH CHRONIC HEPATITIS C GENOTYPE 1
TOROK, NATALIE
APOPTOSIS AND LIVER FIBROGENESIS
ZERN, MARK
DIFFERENTIATING HUMAN EMBRYONIC
STEM CELLS ALONG A HEPATOCYTE
ZERN, MARK
DIFFERENTIATING HUMAN ESC TOWARDS
HEPATOCYTES
ZERN, MARK
ETHANOL EFFECTS ON PRIMATE EMBRYONIC
STEM CELLS
AGUILAR-GAXIOLA, SERPARTNERSHIP FOR CULTURAL CONFLICTS
AGUILAR-GAXIOLA, SERSPEAKING TOGETHER: NATIONAL
LANGUAGE SERVICES NETWORK
BRESLAU, JOSHUA
ETHNIC DISADVANTAGE AND PSYCHIATRIC
MORBIDITY
FANCHER, TONYA
COMPREHENSIVE DIABETES CARE FOR THE
MEDICALLY UNDERSERVED: ASSESSING
HOW INTERNAL MEDICINE RESIDENTS
HENDERSON, MARK
TRANSFORMING EDUCATION AND
COMMUNITY HEALTH (TEACH) PROG
HIRSCH, CALVIN
MULTIPURPOSE SENIOR SERVICES PROG
KRAVITZ, RICHARD
PATIENT COACHING TO IMPROVE THE CARE
OF CANCER PAIN
KRAVITZ, RICHARD
ACCOUNTING FOR HETEROGENEITY OF
TREATMENT EFFECTS IN THE CARE OF
OLDER PATIENTS
KRAVITZ, RICHARD
THE UC DAVIS MIND-BRAIN BODY INTEREST
GROUP
KRAVITZ, RICHARD
N-OF-1 TRIALS: UTILITY AND COST
EFFECTIVENESS
KRAVITZ, RICHARD
UNLEASHING CLINICAL EXPERIENCE
THROUGH EVIDENCE FARMING
KRAVITZ, RICHARD
ACCEPTABILITY OF AND BARRIERS TO N-OF1 TRIALS
KRAVITZ, RICHARD
TARGETED AND TAILORED MESSAGES TO
ENHANCE DEPRESSION CARE AND REDUCE
STIGMA
KRAVITZ, RICHARD
improving care for comorbid physical and
INTERNAL MEDICINE
LANE, NANCY
INTERNAL MEDICINE
LANE, NANCY
INTERNAL MEDICINE
INTERNAL MEDICINE
LANE, NANCY
LANE, NANCY
INTERNAL MEDICINE
INTERNAL MEDICINE
LANE, NANCY
LI, ZHONGMIN
INTERNAL MEDICINE
INTERNAL MEDICINE
PATERNITI, DEBORA
ROBBINS, JOHN
INTERNAL MEDICINE
ROBBINS, JOHN
INTERNAL MEDICINE
ROBBINS, JOHN
INTERNAL MEDICINE
INTERNAL MEDICINE
ROBBINS, JOHN
ROBBINS, JOHN
INTERNAL MEDICINE
ROBBINS, JOHN
INTERNAL MEDICINE
ROBBINS, JOHN
INTERNAL MEDICINE
INTERNAL MEDICINE
ROBBINS, JOHN
ROBBINS, JOHN
INTERNAL MEDICINE
INTERNAL MEDICINE
ROMANO, PATRICK
ROMANO, PATRICK
INTERNAL MEDICINE
TONG, ELISA
INTERNAL MEDICINE
WHITE, RICHARD
A DOSE RANGING STUDY OF THE EFFECTS
OF MACROFLUX PTH COMPARED WITH
MACROFLUX PLACEBO AND FORTE IN
POSTMENOPAUSAL WOMEN WITH
THE EFFECTS OF INTRAVENOUS
IBANDRONATE ON BONE MINERALIZATION
AND BONE STRENGTH
MEDICAL STUDENT RES PRECEPTORSHIP
THE EPIDEMIOLOGY AND GENETICS OF HIP
OA IN ELDERLY MEN
ACADEMIC GERIATRIC RESOURCE CTR
CALIF CORONARY ARTERY BYPASS GRAFT
OUTCOMES REPORTING PROJ
the breast cancer experience of slavic
FRACTURE INCIDENCE REDUCTION AND
SAFETY OF TSE-424 COMPARED TO
PLACEBO AND RALOXIFENE IN
OSTEOPOROTIC POST MENOPAUSAL WOMEN
A PHASE III RANDOMIZED STUDY OF
EXEMESTANE PLUS PLACEBO VERSUS
EXERMASTANE PLUS CELECOXIB VERSUS
PLACEBO IN POSTMENOPAUSAL WOMEN AT
INCREASED RISK OF DEVELOPING BREAST
CANCER
CARDIOVASCULAR HEALTH STUDY TRANSITION PHASE
WOMEN'S HEALTH INITIATIVE
GINKGO EVAL OF MEMORY INFLAMMATION
AND NEUROIMAGING (GEMINI) STUDY
SUBCORTICAL HYPERINTENSITIES IN SLEEP
APNEA SYNDROME
EFFECTS OF EXEMESTANE ON BONE
STRENGTH IN POSTMENOPAUSAL WOMEN
AT INCREASED RISK OF DEVELOPING
BREAST CANCER: MAP.3B A COMPANION
SLEEP HEART HEALTH STUDY
CARDIOVASCULAR HEALTH STUDY EVENTS
FOLLOW UP STUDY
OPA QUALITY MEASURES EVAL PROJ
impact of resident work hour rules on errors
and quality
CALIF VIETNAMESE ADULT TOBACCO USE
SURVEY
A RANDOMIZED, DOUBLE-BLIND, PLACEBOCONTROLLED, MULTI-CENTER STUDY OF
INTERNAL MEDICINE
WHITE, RICHARD
INTERNAL MEDICINE
WHITE, RICHARD
INTERNAL MEDICINE
WHITE, RICHARD
INTERNAL MEDICINE
WHITE, RICHARD
INTERNAL MEDICINE
WHITE, RICHARD
INTERNAL MEDICINE
WHITE, RICHARD
INTERNAL MEDICINE
WILKES, MICHAEL
INTERNAL MEDICINE
WILKES, MICHAEL
INTERNAL MEDICINE
CHEN, MOON
INTERNAL MEDICINE
CHEN, MOON
INTERNAL MEDICINE
CHEN, MOON
RANDOMIZED EVALUATION OF LONG TERM
ANTICOAGULANT THERAPY (RE-LY)
COMPARING THE EFFICACY AND SAFETY OF
TWO BLINDED DOSES DABIGATRAN
ETEXILATE WITH OPEN LABEL WARFARIN
FOR THE PREVENTION OF STROKE AND
SYSTEMIC EMBOLIC EVENTS IN PATIENTS
WITH NON VALVULAR ATRIAL FIBRILLATION
MAVERICK PT/INR TEST SYSTEM CLINICAL
STUDY
PHYSICIANS ALERTS TO PREVENT DVT AND
PULMONARY EMBOLISM IN HOSPITALIZED
PATIENTS
REGULATION OF COAGULATION IN
ORTHOPEDIC SURGERY TO PREVENT DVT
AND PE; A CONTROLLED, DOUBLE BLIND,
RANDOMIZED STUDY OF BAY 59-7639 IN
THE PREVENTION OF VTE IN SUBJECTS
UNDERGOING ELECTIVE TOTAL KNEE
A PHASE II STUDY CLINICAL TRIAL TO
EVALUATE THE ACCURACY OF ANTI-FIBRIN
HUMANIZED MONOCLONAL ANTIBODY (DIDD3B6/22-80B3) FAB PROTEIN FRAGMENT
(THROMBOVIEW) CONJUGATED WITH
TECHNETIUM 99M IN THE DETECTION OF
PULMONARY EMBOLISM
A PHASE III, RANDOMIZED, DOUBLE BLIND,
ACTIVE CONTROLLED, PARALLEL GROUP
MULTICENTER STUDY TO EVALUATE THE
SAFETY AND EFFICACY OF APIXABAN IN
SUBJECTS UNDERGOING ELECTIVE TOTAL
HIP REPLACEMENT SURGERY (CV185035)
INTERVENTIONS TO IMPROVE SHARED
DECISION MAKING: PROSTATE CANCER
SCREENING
STATEWIDE INITIATIVE TO DISSEMINATE
END OF LIFE EDUC
DEVELOPING A SECONDHAND SMOKE
INTERVENTION FOR CHINESE SMOKERS
AND NONSMOKERS (aancart)
hepatocellular carcinoma screening practices
in hbv infected asian americans (aancart)
HEALTH BENEFITS OF EXPRESSIVE WRITING
AMONG CHINESE BREAST CANCER
SURVIVORS (aancart)
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
CHEW, HELEN
CHEW, HELEN
SERUM GLYCAN ANALYSIS IN BREAST
A MULTICENTER, PHASE III, RANDOMIZED,
PLACEBO CONTROLLED TRIAL EVALUATING
THE EFFICACY AND SAFETY OF
BEVACIZUMAB IN COMBINATION WITH
CHEMOTHERAPY REGIMENTS IN SUBJECTS
WITH PREVIOUSLY UNTREATED METASTATIC
A MULTICENTER, PHASE III, RANDOMIZED,
CHEW, HELEN
PLACEBO CONTROLLED TRIAL EVALUATING
THE EFFICACY AND SAFETY OF
BEVACIZUMAB IN COMBINATION WITH
CHEMOTHERAPY REGIMENS IN SUBJECTS
WITH PREVIOUSLY TREATED METASTATIC
CHRISTENSEN, SCOTT A PHASE III STUDY OF SU011248 IN
COMBINATION WITH PACLITAXEL VERSUS
BEVACIZUMAB WITH PACLITAXEL IN THE
FIRST LINE ADVANCED DISEASE SETTING IN
PATIENTS HAVING BREAST CANCER
DAVIES, ANGELA
A PHASE I STUDY OF WEEKLY BORTEZOMIB
(PS341) IN COMBINATION WITH
GEMCITABINE AND CARBOPLATIN IN
PATIENTS WITH ADVANCED SOLID TUMORS,
WITH EMPHASIS ON NON SMALL CELL LUNG
DENARDO, GERALD
TRANSLATIONAL MULTIMODALITY ANTIBODY
THERAPY
GANDARA, DAVID
A RANDOMIZED PHASE III TRIAL OF ALIMTA
(PEMETREXED) AND CISPLATIN VERSUS
GEMZAR (GEMCITABINE) AND CISPLATIN IN
PATIENTS WITH LOCALLY ADVANCED OR
METASTATIC NON-SMALL CELL LUNG
GANDARA, DAVID
INSTITUTIONAL RES GRANT
GANDARA, DAVID
EARLY THERAPEUTICS DEVELOPMENT WITH
PHASE II EMPHASIS
phase i/ii study of erlotinib (tarceva) and
GANDARA, DAVID
cetuximab (erbitux) in advanced solid
tumors, with emphasis on non small cell lung
GANDARA, DAVID
PHASE II OPEN LABEL, MULTICENTER
CLINICAL STUDY OF THE SAFETY AND
EFFICACY OF INTRAVENOUS
ADMINISTRATION OF SNS-595 IN PATIENTS
WITH ADVANCED SMALL CELL LUNG CANCER
A PHASE I/II TRIAL OF ABRAXANE (ABI-007)
GANDARA, DAVID
AND ALIMTA (PEMETREXED) IN ADVANCED
SOLID TUMORS WITH EMPHASIS ON NONSMALL CELL LUNG CANCER AND BREAST
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
KUMARESAN, PAPPANAI NOVEL TARGETED IMMUNOTHERAPY FOR
CML BLAST CELLS
KUMARESAN, PAPPANAI IDENTIFICATION OF PANCREATIC CANCER
SPECIFIC HIGH AFFINITY TARGETING
LAM, KIT
TARGETING AGENTS FOR HUMAN CANINE
LYMPHOMA
LAM, KIT
HIGH AFFINITY LIGAND TO DELIVER
NANOPARTICLE DRUGS TO LYMPHOID
LAM, KIT
ULTRA HIGH THROUGHOUT MULTIPLEX
ASSAY TO SCREEN OBOC COMBICHEM
LAM, KIT
UC DAVIS AP4 GRANT
LAM, KIT
TARGETING AGENTS FOR HUMAN CANINE
LYMPHOMA
LAM, KIT
THERAPEUTIC TARGETING AGENTS FOR
OVARIAN CANCER
LAM, KIT
C-SRC INHIBITORS FROM NOVEL ENCODED
CHEMICAL LIBRARIES
LAM, KIT
THERAPEUTIC TARGETING AGENTS FOR
OVARIAN CANCER
THERAPEUTIC TARGETING AGENTS FOR
LAM, KIT
OVARIAN CANCER
LARA, PRIMO
A MULTICENTER, MULTI NATIONAL, DOUBLE
BLIND, RANDOMIZED PHASE III STUDY OF
SATRAPLATIN PLUS PREDNISONE OR
PLACEBO PLUS PREDNISONE IN PATIENTS
WITH HORMONE REFRACTORY PROSTATE
CANCER PREVIOUSLY TREATED WITH ONE
CYTOTOXIC CHEMOTHERAPY REGIMEN
LARA, PRIMO
A PHASE III, RANDOMIZED, OPEN LABEL
STUDY EVALUATING DN-101 IN
COMBINATION WITH DOCETAXEL IN
ANDROGEN INDEPENDENT PROSTATE
LARA, PRIMO
A RANDOMIZED, CONTROLLED TRIAL
COMPARING SAFETY AND EFFICACY OF
CARBOPLATIN AND PACLITAXEL PLUS OR
MINUS SORAFENIB (BAY 43-9006) IN
CHEMONAIVE PATIENTS WITH STAGE IIIB-IV
NON SMALL CELL LUNG CANCER
LARA, PRIMO
INHIBITION OF AURORA KINASE ACTIVITY
IN HUMAN CANCER: PRECLINICAL STUDIES
LARA, PRIMO
A RANDOMIZED, DOUBLE BLIND, PLACEBO
CONTROLLED MULTICENTER PHASE III
STUDY TO COMPARE THE SAFETY AND
EFFICACY OF RAD001 PLUS BEST
SUPPORTIVE CARE VERSUS BEST
INTERNAL MEDICINE
LARA, PRIMO
INTERNAL MEDICINE
LARA, PRIMO
INTERNAL MEDICINE
LARA, PRIMO
INTERNAL MEDICINE
LARA, PRIMO
INTERNAL MEDICINE
LAU, DERICK
INTERNAL MEDICINE
INTERNAL MEDICINE
LAU, DERICK
LUO, JUNTAO
INTERNAL MEDICINE
MACK, PHILIP
INTERNAL MEDICINE
MACK, PHILIP
INTERNAL MEDICINE
MACK, PHILIP
INTERNAL MEDICINE
INTERNAL MEDICINE
MACK, PHILIP
MACK, PHILIP
INTERNAL MEDICINE
MACK, PHILIP
A MULTICENTER PHASE II RANDOMIZED
DOUBLE BLIND PLACEBO CONTROLLED
TRIAL EVALUATING THE EFFICACY AND
SAFETY OF SUNITINIB WITH OR WITHOUT
BEVACIZUMAB IN FIRST LINE PATIENTS
WITH METASTATIC RENAL CANCER
A PHASE II STUDY OF XL47 IN SUBJECTS
WITH NON SMALL CELL LUNG CANCER WHO
HAVE PROGRESSED AFTER RESPONDING TO
TREATMENT WITH EITHER GEFITINIB OR
ERLOTINIB
A RANDOMIZED, DOUBLE BLIND,
MULTICENTER STUDY OF DENOSUMAB
COMPARED WITH ZOLEDRONIC ACID
(ZOMETA) IN THE TREATMENT OF BONE
METASTASES IN MEN WITH HORMONEREFRACTORY PROSTATE CANCER
BIOCHEMICAL MARKERS OF BONE
TURNOVER IN METASTATIC PROSTATE
PHASE I STUDY OF PACLITAXEL
POLIGLUMEX AND RADIATION FOR
SQUAMOUS CANCER OF THE HEAD AND
treatment of lung cancer
NOVEL POLYMERIC TARGETING
NANOCARRIER FOR THE DETECTION AND
TREATMENT OF MULTIPLE MYELOMA
CORRELATIVE STUDIES FOR CLINICAL
PROTOCOL P7097: A PHASE II STUDY OF
AZD 2171 IN PATIENTS WITH RECURRENT
SMALL CELL LUNG CANCER
CORRELATIVE STUDIES FOR CLINICAL
PROTOCOL P7077: A RANDOMIZED PHASE
II TRIAL OF SEQUENTIAL VERSUS
CONCURRENT DOCETAXEL AND PS-341 IN
PREVIOUSLY TREATED NON SMALL CELL
HYPOXIA INDUCED PROTEINS AS LUNG
CANCER BIOMARKERS
swog study chair, lung cancer committee
A PHASE II STUDY OF TIRZPAZAMINE/
CISPLATIN/ ETOPOSIDE AND CONCURRENT
THORACIC RADIOTHERAPY FOR LIMITED
STAGE SMALL CELL LUNG CANCER,
A PHASE II SELECTION DESIGN TRIAL OF
CONCURRENT CHEMOTHERAPY AND
CETUXIMAB VS. CHEMOTHERAPY FOLLOWED
INTERNAL MEDICINE
MACK, PHILIP
INTERNAL MEDICINE
INTERNAL MEDICINE
MEYERS, FRED
MEYERS, FRED
INTERNAL MEDICINE
NOLTA, JAN
INTERNAL MEDICINE
NOLTA, JAN
INTERNAL MEDICINE
O’DONNELL, ROBERT
INTERNAL MEDICINE
PAN, CHONG-XIAN
INTERNAL MEDICINE
PAN, CHONG-XIAN
INTERNAL MEDICINE
POWELL, JERRY
INTERNAL MEDICINE
POWELL, JERRY
INTERNAL MEDICINE
SCUDDER, SIDNEY
INTERNAL MEDICINE
SCUDDER, SIDNEY
INTERNAL MEDICINE
TUSCANO, JOSEPH
CORRELATE STUDY FOR PROTOCOL #S0536,
A PHASE II TRIAL OF COMBINATION
CARBOPLATIN, PACLITAXEL, CETUXIMAB
AND BEVACIZUMAB (NSC-704865)
FOLLOWED BY CETUXIMAB AND
BAVACIZUMAB IN PATIENTS WITH
ADVANCED NON SMALL CELL LUNG CANCER
STEM CELL RESEARCH TRAINING GRANT
SIMULTANEOUS CARE: LINKING PALLIATION
TO CLINICAL TRIALS
immunodeficient mouse model of stem cell
plasticity
AXP ISOLATED STEM CELL TESTING IN
IMMUNE DEFICIENT MOUSE MODELS OF
REVASCULARIZATION AND TISSUE REPAIR
PHASE I/II CLINICAL TRIAL OF HHB22.7
ANTI CD22 MONOCLONAL ANTIBODY FOR
TISSUE SPECIFIC GENE THERAPY FOR
BRONCHIOALVEOLAR CARCINOMA
OPTIMIZATION OF BLADDER CANCER
SPECIFIC LIGANDS
A RANDOMIZED, TWO WAY BLINDED
CROSSOVER DESIGN STUDY TO ESTABLISH
THE BIOEQUIVALENCE OF B-DOMAIN
DELETED RECOMBINANT FACTOR VIII WITH
A FULL LENGTH RECOMBINANT FACTOR VIII
PREPARATION FOLLOWED BY AN OPEN
LABEL TRIAL OF THE SAFETY AND EFFICACY
OF REFACTO AG IN PREVIOUSLY TREATED
PATIENTS WITH HEMOPHILIA A
REGION IX COMPREHENSIVE HEMOPHILIA
CARE PROG
A RANDOMIZED, OPEN LABEL,
MULTICENTER, PHASE III TRIAL OF
PATUPILONE (EPO906) VERSUS PEGYLATED
LIPOSOMAL DOXONRUBICIN IN PLATINUM
REFRACTORY RESISTANT PATIENTS WITH
RECURRENT EPITHELIAL OVARIAN, PRIMARY
FALLOPIAN OR PRIMARY PERITONEAL
PHASE I/II STUDY OF ZK-EPOTHILONE (ZK
219477) IN COMBINTION WITH
CARBOPLATIN IN PATIENTS WITH PLATINUM
SENSITIVE, RECURRENT OVARIAN CANCER
TARGETED LYMPHOMA CELL DEATH BY
NOVEL SIGNAL TRANSDUCTION
INTERNAL MEDICINE
WUN, THEODORE
INTERNAL MEDICINE
WUN, THEODORE
INTERNAL MEDICINE
WUN, THEODORE
INTERNAL MEDICINE
INTERNAL MEDICINE
WUN, THEODORE
WUN, THEODORE
INTERNAL MEDICINE
YAO, NIANHUAN
INTERNAL MEDICINE
ZOU, JUNE
INTERNAL MEDICINE
ASMUTH, DAVID
INTERNAL MEDICINE
ASMUTH, DAVID
INTERNAL MEDICINE
ASMUTH, DAVID
INTERNAL MEDICINE
ASMUTH, DAVID
AN OPEN LABEL EXTENSION STUDY
EVALUATING THE LONG TERM SAFETY OF
ICA-17043 WITH OR WITHOUT
HYDROXYUREA THERAPY IN SUBJECTS WITH
SICKLE CELL DISEASE
BEST PRACTICES IN TRANSFUSION FOR
PATIENTS WITH SICKLE CELL DISEASES
RANDOMIZED TRIAL OF ORAL
DEXAMETHASONE FOR ACUTE CHEST
EPIDEMIOLOGY OF PPRIAPISM
EFFECTIVENESS OF HYDROXYUREA AND
MAGNESIUM PIDOLATE ALONE AND IN
COMBINATION IN HEMOGLOBIN SC
DISEASE: A PHASE II TRIAL
DEVELOPMENT OF RADIO TARGETING
PEPTIDES FOR BREAST CANCER
IDENTIFY SMALL MOLECULE INHIBITORS
BLOCKING ANDROGEN RECEPTOR FUNCTION
IN PROSTATE CANCER
A PHASE I DOSE RANGING STUDY OF THE
SAFETY, TOLERABILITY AND
IMMUNOGENICITY OF THE MERCK
TRIVALENT ADENOVIRUS SEROTYPE 5 HIV-1
GAG/POL/NEF VACCINE IN A PRIME BOOST
A PHASE I DOSE RANGING STUDY OF THE
SAFETY, TOLERABILITY, AND
IMMUNOGENICITY OF A 3-DOSE REGIMEN
OF THE MRKAD5 HIV-1 TRIGENE AND THE
MRKAD6 HIV-1 TRIGENE VACCINES ALONE
AND THE COMBINATION IN HEALTHY
A STUDY TO EVALUATE THE SAFETY,
TOLERABILITY, AND IMMUNOGENICITY OF
HUMAN IMMUNDEFICIENCY VIRUS TYPE 1
GAG DNA VACCINE FORMULATED WITH
PHOSPHATE BUFFERED SALINE OR WITH
ALUMINUM PHOSPHATE, FOLLOWED BY AD5
HIV-1, GAG VACCINE IN A PRIME BOOST
REGIMEN IN HEALTHY ADULTS
A STUDY OF SAFETY, TOLERABILITY AND
IMMUNOGENICITY OF HUMAN
IMMUNODEFICIENCY VIRUS TYPE I (HIV-1)
GAG DNA FORMULATED WITH CRL1005
ADJUVANT FOLLOWED BY THE ADENOVIRUS
SEROTYPE 5 HIV-1 VACCINE (AD5 HIV-1
GAG) IN A PRIME/BOOST REGIMEN
INTERNAL MEDICINE
ASMUTH, DAVID
INTERNAL MEDICINE
ASMUTH, DAVID
INTERNAL MEDICINE
ASMUTH, DAVID
INTERNAL MEDICINE
COHEN, STUART
INTERNAL MEDICINE
FLYNN, NEIL
INTERNAL MEDICINE
FLYNN, NEIL
INTERNAL MEDICINE
NGUYEN, HIEN
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
A PHASE IIA DOSE REFINEMENT STUDY OF
THE SAFETY AND IMMUNOGENICITY OF A
THREE DOSE REGIMEN OF THE MERCK
ADENOVIRUS SEROTYPE 5 HIV-1
GAG/POL/NEF VACCINE IN HEALTHY ADULTS
EARLY ACCESS OF TMC125 IN
COMBINATION WITH OTHER
ANTIRETROVIRALS IN TREATMENT
EXPERIENCED HIV-1 INFECTED SUBJECTS
WITH LIMITED TREATMENT OPTIONS
GASTROINTESTINAL ASSOCIATED
LYMPHOID TISSUE IMMUNE
RECONSTITUTION FOLLOWING
EPIDEMIOLOGY OF METHICILLIN RESISTANT
STAPHYLOCOCCUS AUREUS (MRSA)
INFECTION AMONG HIV INFECTED PATIENTS
IN SACRAMENTO
MINORITY AIDS INITIATIVE, STREET
OUTREACH DIRECTLY OBSERVED THERAPY
TO IMPROVE ANTIRETROVIRAL MEDICATION
ADHERENCE
PREVENTION INTERVENTION STRATEGIES
WITH HIV INFECTED PERSONS AS SEEN IN
FOUR DIFFERENT CLINICAL SETTINGS
CUBICIN OUTCOMES REGISTRY AND
EXPERIENCE (CORE) FOR THE TREATMENT
OF SERIOUS GRAM POSITIVE INFECTIONS
A PILOT I/II RANDOMIZED PLACEBO
CONTROLLED TRIAL TO ASSESS THE SAFETY
AND EFFICACY OF INTRAVENOUS
IMMUNOGLOBULIN G CONTAINING HIGH
ANTI-WEST NILE VIRUS ANTIBODY TITERS
IN PATIENTS WITH OR AT HIGH RISK FOR
PROGRESSION TO WEST NILE VIRUS
ENCEPHALITIS OF MYELITIS
A PHASE I, MULTICENTER, RANDOMIZED,
DOUBLE BLIND, ADJUVANT CONTROLLED
TRIAL TO EVALUATE THE SAFETY AND
IMMUNOGENICITY OF AN HIV CTL MULTIEPITOPE PEPTIDE VACCINE FORMULATED
WIT RC529-SE AND GM-CSF GIVEN TO HIV1 POSITIVE ADULTS RECEIVING STABLE
CALIFORNIA RES CTR FOR THE BIOLOGY OF
HIV IN MINORITIES
AN OPEN LABEL TRIAL OF TELBIVUDINE
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
INTERNAL MEDICINE
POLLARD, RICHARD
A PHASE III, RANDOMIZED, OPEN LABEL
STUDY OF LOPINAVIR/RITONAVIR TABLETS
800/200 MG ONCE DAILY VERSUS 400/100
MG TWICE DAILY WHEN CO-ADMINISTERED
WITH NUCLEOSIDE/NUCLEOTIDE REVERSE
TRANSCRIPTASE INHIBITORS IN ANTIRETROVIRAL, EXPERIENCED HIV-1
AN OPEN LABEL, MULTICENTER TRIAL TO
COMPARE THE EFFICACY, SAFETY AND
TOLERABILITY OF PREZISTA/R BY GENDER
AND RACE, WHEN ADMINISTERED IN
COMBINATION WITH AN INDIVIDUALLY
OPTIMIZED BACKGROUND REGIMEN OVER A
48 WEEK TREATMENT PERIOD
AN OPEN LABEL, MULTICENTER, MECHANISM
VALIDATION STUDY TO EVALUATE THE
SAFETY, EFFICACY AND TOLERABILITY OF KP
1461 AS MONOTHERAPY FOR 124 DAYS IN
ARV-EXPERIENCED HIV 1-INFECTED
SAFETY AND EFFICACY STUDY OF TPV
BOOSTED WITH LOW DOSE RITONAVIR
(TPV/R) 500 MG/200 MG BID IN
ANTIRETROVIRAL TREATMENT HIV POSITIVE
PATIENTS WITH HCV OR HBV CO-INFECTION
WITH A PILOT EVAL OF THERAPEUTIC DRUG
MONITORING (TDM). AN OPEN LABEL,
MULTICENTER, MULTINATIONAL TRIAL WITH
RANDOMISATION TO STANDARD OF CARE
OR TDM TPV/R THERAPY
SAFETY, EFFICACY AND
PHARMACOKINETICS OF TIPRANAVIR
BOOSTED WITH LOW DOSE RITONAVIR 500
MG/200 MG BID IN A RACIALLY AND
GENDER DIVERSE HIV POSITIVE TREATMENT
EXPERIENCED POPULATION WITH A PILOT
EVAL OF THERAPEUTIC DRUG MONITORING.
THE SPRING STUDY IS AN OPEN LABEL,
MULTICENTER, MULTINATIONAL TRIAL WITH
RANDOMIZATION TO STANDARD OF CARE
AIDS CLINICAL TRIALS GROUP NETWORK
(IMMUNOLOGY SUPPORT LAB)
AN IMMUNOLOGY SUBSTUDY TO EVALUATE
IMMUNE RECOVERY BETWEEN MEN AND
WOMEN ON A DARUNAVIR BASED REGIMEN
OVER A 48 WEEK TREATMENT PERIOD
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
POLLARD, RICHARD
VICRIVIROC IN COMBINATION TREATMENT
WITH AN OPTIMIZED ART REGIMEN IN HIV
INFECTED TREATMENT EXPERIENCED
SUBJECTS (VICTOR-E4)
SOLNICK, JAY
GENE EXPRESSION DURING H. PYLORIHOST INTERACTIONS
SOLNICK, JAY
ANIMAL MODELS OF INFECTIOUS DISEASES
TRAINING PROG
SOLNICK, JAY
GENE EXPRESSION DURING H. PYLORIHOST INTERACTIONS
SOLNICK, JAY
GENE EXPRESSION DURING H. PYLORIHOST INTERACTIONS (FOGARTY)
DON, BURL
THE EFFECT OF ETANERCEPT IN
SUPPRESSION OF THE SYSTEMIC
INFLAMMATORY RESPONSE IN
KAYSEN, GEORGE
THE EFFECT OF PROTEINURIA ON
LIPOPROTEIN STRUCTURE AND FUNCTION
KAYSEN, GEORGE
THE EFFECT OF ETANERCEPT TNFR:FC IN
SUPPRESSION OF THE SYSTEM
INFLAMMATORY RESPONSE IN
HEMODIALYSIS PATIENTS
WEISS, ROBERT
PROTEOMIC AND METABOLOMIC DISCOVERY
OF BIOFLUID MARKERS OF KIDNEY CANCER
WEISS, ROBERT
METABOLOMIC DISCOVERY AND
VALIDATION OF BIOMARKERS IN KIDNEY
WEISS, ROBERT
P21 AS A NOVEL TARGET FOR AUTOSOMAL
DOMINANT POLYCYSTIC KIDNEY DISEASE
THERAPY
ALBERTSON, TIMOTHY 2007 PFIZER VISITING PROFESSORSHIP IN
PULMONARY
ALBERTSON, TIMOTHY CLINICAL CENTERS FOR A CLINICAL RES
NETWORK FOR THE TREATMENT OF ACUTE
LUNG INJURY AND ACUTE RESPIRATORY
DISTRESS SYNDROME
ALLEN, ROBLEE
A LONG TERM STUDY OF AMBRISENTAN IN
PULMONARY ARTERIAL HYPERTENSION
SUBJECTS HAVING COMPLETED AMB-320 OR
AMB-321
ALLEN, ROBLEE
COMPASS 2: EFFECTS OF COMBINATION OF
BOSENTAN AND SILDENAFIL VERSUS
SILDENAFIL MONOTHERAPY ON MORBIDITY
AND MORTALITY IN SYMPTOMATIC
PATIENTS WITH PULMONARY ARTERIAL
ALLEN, ROBLEE
TDE-PH-302: A 12 WEEK, INTERNATIONAL,
MULITCENTER, DOUBLE BLIND,
INTERNAL MEDICINE
ALLEN, ROBLEE
INTERNAL MEDICINE
ALLEN, ROBLEE
INTERNAL MEDICINE
CHAN, ANDREW
INTERNAL MEDICINE
CHAN, ANDREW
INTERNAL MEDICINE
CHAN, ANDREW
INTERNAL MEDICINE
CHAN, ANDREW
INTERNAL MEDICINE
CHAN, ANDREW
INTERNAL MEDICINE
CROSS, CARROLL
INTERNAL MEDICINE
GOLDKORN, TZIPORA
INTERNAL MEDICINE
HARPER, RICHART
A RANDOMIZED DOUBLE BLIND PLACEBO
CONTROLLED STUDY TO EVALUATE THE
SHORT TERM EFFICACY AND SAFETY OF PRX08066 IN PATIENTS WITH PULMONARY
HYPERTENSION SECONDARY TO CHRONIC
OBSTRUCTIVE PULMONARY DISEASE
A MULTINATIONAL, MULTICENTER,
RANDOMIZED, PARALLEL GROUP, DOUBLE
BLIND STUDY TO ASSESS THE EFFICACY
AND SAFETY OF 1 MG, 5 MG AND 20 MG TID
OF ORAL SILDENAFIL IN THE TREATMENT OF
SUBJECTS AGED 18 YEARS AND OVER WITH
PULMONARY ARTERIAL HYPERTENSION
A RANdomized, double blind, placebo
controlled, phase iii study of the efficacy of
interferon gamma-1b in patients with
idiopathic pulmonary fibrosis
A RANDOMIZED, DOUBLE BLIND, PLACEBO
CONTROLLED, PHASE III, THREE ARM STUDY
OF THE SAFETY AND EFFICACY OF
PIRFENIDONE IN PATIENTS WITH
IDIOPATHIC PULMONARY FIBROSIS (PIPF
EASE STUDY: A RANDOMIZED, DOUBLE
BLIND STUDY TO EVALUATE THE SAFETY
AND EFFECTIVENESS OF THE EXHALE DRUG
ELUTING STENT IN HOMOGENEOUS
EMPHYSEMA SUBJECTS WITH SEVERE
HYPERINFLATION
a prospective, randomized, controlled
multicenter clinical trial to evaluate the
safety and effectiveness of the ibv valve
system for the treatment of severe
A RANDOMIZED, DOUBLE BLIND, PLACEBO
CONTROLLED, PARALLEL GROUP, 6 WEEK
CLINICAL STUDY TO ASSESS THE EFFECT OF
INHALED ACLIDINIUM BROMIDE (LAS34273)
200UG ON EXERCISE ENDURANCE AND
LUNG HYPERINFLATION IN PATIENTS WITH
MODERATE TO SEVERE CHRONIC
OBSTRUCTIVE PULMONARY DISEASE
VITAMIN E METABOLISM AND LUNG
TOXICOLOGY
PROTEASOME ERBB1 INTERACTION IN LUNG
HYPERPLASIA
THIOREDOXIN LOCALIZATION AND ITS
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
INTERNAL MEDICINE
MORRISSEY, BRIAN
MORRISSEY, BRIAN
UC DAVIS CLINICAL RES FACILITATION
2007/2008 CYSTIC FIBROSIS CTR
ACCREDITATION AND FUNDING
SANDROCK, CHRISTIAN CALIF PREPAREDNESS EDUC NETWORK
(CALPEN)
THAI, PHILIP
SMOKE AND ES CELL DERIVED AIRWAY
MUCOUS CELL REGENERATION
THARRATT, STEVEN
A MULTICENTER STUDY TO EVALUATE THE
EFFECT OF AN EDUC PROG ON PREHOSPITAL
PEDIATRIC PAIN MANAGEMENT PAMPPER
WU, REEN
REGENERATIVE AIRWAY EPITHELIUM BY
EMBRYONIC STEM CELLS
WU, REEN
EPIGENETIC REGULATION OF AIRWAY MUC
GENE EXPRESSION BY SMOKE
WU, REEN
PROGRAMMING AIRWAY EPITHELIAL CELL
DIFFERENTIATION BY RAD
WU, REEN
TRAINING IN COMPARATIVE LUNG BIOLOGY
AND MEDICINE
WU, REEN
IL-17 MEDIATED MUC GENE EXPRESSION IN
AIRWAY EPITHELIUM
WU, REEN
VISITING PROFESSORSHIP
GERSHWIN, ERIC
EFFECTS OF RITUXIMAB ON B CELL AND
AMA RESPONSE IN PATIENTS WITH PRIMARY
BILIARY CIRRHOSIS
GERSHWIN, ERIC
XENOBIOTICS of PRIMARY BILIARY
GERSHWIN, ERIC
EPIDEMIOLOGY OF PRIMARY BILIARY
SCLEROSIS: A GENOME WIDE
ASSOCIATION STUDY\
GERSHWIN, ERIC
THE PATHOGENESIS OF AUTOIMMUNITY IN
A MURINE MODEL OF PRIMARY BILIARY
CIRRHOSIS
GERSHWIN, ERIC
MECHANISMS AND PATHOGENESIS OF
PRIMARY BILIARY CIRRHOSIS
GERSHWIN, ERIC
rheumatology fellowship prog
GERSHWIN, ERIC
RHEUMATOLOGY FELLOWSHIP PROG
SELMI, CARLO
EPIGENETICS OF X-LINKED GENES IN PBC:
DOES X MARK THE SPOT?
SELMI, CARLO
EFFECTS OF CRANBERRY JUICE
CONSTITUENTS ON THE ANTIBODY
RESPONSE TO INFLUENZA VACCINE IN THE
ELDERLY: A RANDOMIZED CONTROLLED
SELMI, CARLO
EPIGENETICS OF X-LINKED GENES IN
SCLERODERMA: DOES X MARK THE SPOT?
SELMI, CARLO
EPIGENETICS OF X-LINKED GENES IN PBC:
DOES X MARK THE SPOT?
MEDICAL MICROBIOLOGY & IMMUNOLOGY
DANDEKAR, SATYA
MEDICAL MICROBIOLOGY & IMMUNOLOGY
DANDEKAR, SATYA
MEDICAL MICROBIOLOGY & IMMUNOLOGY
DANDEKAR, SATYA
MEDICAL MICROBIOLOGY & IMMUNOLOGY
DANDEKAR, SATYA
MEDICAL MICROBIOLOGY & IMMUNOLOGY
DANDEKAR, SATYA
MEDICAL MICROBIOLOGY & IMMUNOLOGY
GEORGE, MICHAEL
MEDICAL MICROBIOLOGY & IMMUNOLOGY
LA SALLE, JANINE
MEDICAL MICROBIOLOGY & IMMUNOLOGY
LA SALLE, JANINE
MEDICAL MICROBIOLOGY & IMMUNOLOGY
MEDICAL MICROBIOLOGY & IMMUNOLOGY
LA SALLE, JANINE
LA SALLE, JANINE
MEDICAL MICROBIOLOGY & IMMUNOLOGY
LUCKHART, SHIRLEY
MEDICAL MICROBIOLOGY & IMMUNOLOGY
LUCKHART, SHIRLEY
MEDICAL MICROBIOLOGY & IMMUNOLOGY
MUDRYJ, MARIA
MEDICAL MICROBIOLOGY & IMMUNOLOGY
MEDICAL MICROBIOLOGY & IMMUNOLOGY
TORRES, JOSE
TSOLIS, RENEE
MEDICAL MICROBIOLOGY & IMMUNOLOGY
TSOLIS, RENEE
MEDICAL MICROBIOLOGY & IMMUNOLOGY
TSOLIS, RENEE
MEDICAL PHARMACOLOGY & TOXICOLOGY
BONHAM, ANN
MEDICAL PHARMACOLOGY & TOXICOLOGY
BONHAM, ANN
MEDICAL PHARMACOLOGY & TOXICOLOGY
CHEN, CHAO-YIN
MEDICAL PHARMACOLOGY & TOXICOLOGY
DIAZ, ELVA
MEDICAL PHARMACOLOGY & TOXICOLOGY
DIAZ, ELVA
MEDICAL PHARMACOLOGY & TOXICOLOGY
DIAZ, ELVA
HIV RESERVOIR AND CD4 REPOPULATION IN
GUT LYMPHOID TISSUE
MECHANISMS OF PROTECTIVE IMMUNITY
INDUCED BY LIVE ATTENUATED SIV
INTESTINAL CYTOKINE AND T CELL
HOMEOSTASIS IN SIV INFECTION
pathogenesis of intestinal dysfunction in
simian aids
PATHOGENESIS OF INTESTINAL
DYSFUNCTION IN SIMIAN AIDS
HOST RESPONSE AND PATHOGENESIS IN
THE ORAL CAVITY DURING SIV INFECTION
INVESTIGATION OF NOVEL MECP2 TARGET
GENES REGULATING NEURONAL
EPIGENETIC ETIOLOGIES OF AUTISM
SPECTRUM DISORDERS
THE ROLE OF MECP2 IN RETT SYNDROME
EPIGENETIC INTERACTION OF MECP2 AND
ORGANIC POLLUTANTS IN
CROSSTALK AMONG MOSQUITO AND
MAMMALIAN IMMUNE FACTORS
PLASMODIUM SIGNALING OF INNATE
IMMUNITY IN ANOPHELES
CALPAIN-DEPENDENT PROTEOLYSIS OF THE
ANDROGEN RECEPTOR
long term non-progressor resistance factors
IDENTIFICATION OF BRUCELLA TYPE IV
EFFECTORS
CHARACTERIZATION OF THE BRUCELIA
ABORTUS VIRB LOCUS
REGIONAL VI CTR FOR BIODEFENSE AND
EMERGING INFECTIONS
air pollutants: cardiovascular effects and
mechanisms
METABOTROPIC GLUTAMATE RECEPTORS
AND BARORECEPTOR INPUT
PARTICULATE MATTER EXPOSURE:
CARDIOVASCULAR MECHANISMS
CHARACTERIZATION OF NOVEL MEMBRANE
PROTEINS IN SYNAPSE FORMATION
a novel family of transmembrane proTeins
that regulate synaptic differentiation
MOLECULAR MECHANISMS OF CEREBELLAR
GRANULE CELL PROLIFERATION AND
MEDULLOBLASTOMA
MEDICAL PHARMACOLOGY & TOXICOLOGY
SEGAL, DAVID
MEDICAL PHARMACOLOGY & TOXICOLOGY
WULFF, HEIKE
MEDICAL PHARMACOLOGY & TOXICOLOGY
WULFF, HEIKE
MEDICAL PHARMACOLOGY & TOXICOLOGY
WULFF, HEIKE
MEDICAL PHARMACOLOGY & TOXICOLOGY
WULFF, HEIKE
MEDICAL PHARMACOLOGY & TOXICOLOGY
WULFF, HEIKE
MEDICAL PHARMACOLOGY & TOXICOLOGY
WULFF, HEIKE
NEUROLOGICAL SURGERY
BERMAN, ROBERT
NEUROLOGICAL SURGERY
KIM, KEE
NEUROLOGICAL SURGERY
KIM, KEE
NEUROLOGICAL SURGERY
KIM, KEE
NEUROLOGICAL SURGERY
KIM, KEE
NEUROLOGICAL SURGERY
KIM, KEE
SEER - A NOVEL METHOD FOR THE
DETECTION OF GENETIC SEQUENCES
BLOCK OF LENS AND NEURONAL GAP
JUNCTIONS BY QUININE
SK CHANNEL OPENERS AS THERAPEUTICS
FOR CEREBELLAR ATAXIA
K+ CHANNELS IN LYMPHOCYTE FUNCTION
AND AUTOIMMUNITY
SMALL MOLECULE KV1-3 BLOCKERS AS NEW
THERAPEUTICS FOR MULTIPLE SCLEROSIS
ALKOXYPSORALENS, SMALL MOLECULE
BLOCKERS OF THE VOLTAGE GATED KV1-3
CHANNEL
SK CHANNEL OPENERS AS THERAPEUTICS
FOR CEREBELLAR ATAXIA
MOUSE MODELS OF FXTAS: DEFINING
CRITICAL PERIODS AND MOLECULAR
TARGETS (HAGERMAN 3 OF 6)
CLINICAL OUTCOME OF LUMBAR
DEGENERATIVE DISC DISEASE TREATED
WITH ANTERIOR TENSION BAND SYSTEM
(ATB) WITH ALIF/FRA SPACER
A PROSPECTIVE, MULTI-CENTER,
RANDOMIZED CONTROLLED STUDY TO
COMPARE THE SPINAL SEALANT SYSTEM AS
AN ADJUNCT TO SUTURED DURAL REPAIR
WITH STANDARD OF CARE METHODS
A MULTICENTER, PROSPECTIVE,
RANDOMIZED, CONTROLLED CLINICAL
TRIAL COMPARING THE SAFETY AND
EFFECTIVENESS OF THE MOBI-C
PROSTHESIS TO CONVENTIONAL ANTERIOR
CERVICAL DISCECTOMY AND FUSION IN THE
TREATMENT OFSYMPTOMATIC
A PROSPECTIVE, MULTI CENTER,
RANDOMIZED CONTROLLED STUDY TO
COMPARE THE SPINAL SEALANT SYSTEM AS
AN ADJUNCT TO SUTURED DURAL REPAIR
WITH STANDARD OF CARE METHODS
DURING SPINAL SURGERY (DS3-06-002)
RANDOMIZED, THIRD PARTY BLINDED,
MULTICENTER CLINICAL TRIAL OF OXIPLEX/
SP GEL FOR THE REDUCTION OF
POSTOPERATIVE EPIDURAL FIBROSIS AND
RELATED SYMPTOMS FOLLOWING LUMBAR
NEUROLOGICAL SURGERY
NEUROLOGICAL SURGERY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
MUIZELAAR, JAN PAUL A MULTICENTER, OBSERVATIONAL STUDY
TO EVALUATE DYNAMICS OF ENDOTHELIN
AND MARKERS OF CELLULAR APOPTOSIS IN
CEREBROSPINAL FLUID AND PLASMA IN
MODERATE AND SEVERE HUMAN HEAD
REISER, KAREN
STRUCTURE/ FUNCTION RELATIONSHIPS IN
ANNULUS FIBROSIS
AGIUS, MARK
INTERNATIONAL, RANDOMIZED,
MULTICENTER, PHASE III STUDY IN
PATIENTS WITH RELAPSING-REMITTING
MULTIPLE SCLEROSIS COMPARING OVER A
TREATMENT PERIOD OF 104 WEEKS
AGIUS, MARK
a multi-national, multicenter, randomized,
double-blind, placebo controlled, parallel
group study to evaluate the effect of early
glatiramer acetate treatment in delaying the
conversion to clinically definite multiple
sclerosis of subjects presenting with a
clinically isolated syndrome
A MULTICENTER, DOUBLE BLIND,
AGIUS, MARK
RANDOMIZED STUDY COMPARING THE
COMBINED USE OF INTERFERON BETA-1A
AND GLATIRAMER ACETATE TO EITHER
AGENT ALONE IN PATIENTS WITH
RELAPSING MULTIPLE SCLEROSIS (COMBIRXAGIUS, MARK
CANNABIS FOR SPASTICITY IN MULTIPLE
SCLEROSIS: PLACEBO-CONTROLLED STUDY
AGIUS, MARK
OPEN LABEL EXTENSION STUDY TO
EVALUATE THE SAFETY, TOLERABILITY AND
ACTIVITY OF ORAL FAMPRIDINE-SR IN
SUBJECTS WITH MULTIPLE SCLEROSIS WHO
PARTICIPATED IN THE MS-F203 TRIAL
AGIUS, MARK
BIOMARKERS IN MULTIPLE SCLEROSIS
STUDY PROTOCOL #5--N063
AGIUS, MARK
AN OPEN LABEL, MULTICENTER, EXTENSION
STUDY TO EVALUATE THE SAFETY AND
TOLERABILITY OF NATALIZUMAB
FOLLOWING RE-INITIATION OF DOSING IN
MULTIPLE SCLEROSIS SUBJETS WHO HAVE
COMPLETED STUDY C-1801, C-1802 OR C1803 AND A DOSING SUSPENSION SAFETY
AGIUS, MARK
A 24 MONTH DOUBLE BLIND, RANDOMIZED,
MULTICENTER, PLACEBO CONTROLLED,
PARALLEL GROUP STUDY COMPARING THE
EFFICACY AND SAFETY OF 0.5 MG AND 1.25
MG FINGOLIMOD (FTY720) ADMINISTERED
ORALLY ONCE DAILY VERSUS PLACEBO IN
PATIENTS WITH RELAPSING REMITTING
MULTIPLE SCLEROSIS
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
NEUROLOGY
AGIUS, MARK
FORTE: A MULTINATIONAL, MULTICENTER,
RANDOMIZED, PARALLEL GROUP, DOUBLE
BLIND STUDY TO COMPARE THE EFFICACY,
TOLERABILITY AND SAFETY OF GLATIRAMER
ACETATE INJECTION 40 MG/ML TO THAT OF
GLATIRAMER ACETATE INJECTION 20 MG/ML
ADMINISTERED ONCE DAILY BY
SUBCUTANEOUS INJECTION IN SUBJECTS
WITH RELAPSING REMITTING MULTIPLE
AGIUS, MARK
DOUBLE BLIND, PLACEBO CONTROLLED, 13
WEEK, PARALLEL GROUP STUDY TO
EVALUATE SAFETY AND EFFICACY OF ORAL
FAMPRIDINE SR (10 MG BID) IN PATIENTS
WITH MULTIPLE SCLEROSIS
AGIUS, MARK
tygris: tysabri global observational prog in
safety
AGIUS, MARK
A DOUBLE BLIND, PLACEBO CONTROLLED,
MULTI CENTER STUDY TO EVALUATE THE
EFFICACY AND SAFETY OF MBP8298 IN
SUBJECTS WITH SECONDARY PROGRESSIVE
MULTIPLE SCLEROSIS
INTERNATIONAL, MULTICENTER, PHASE IIIB
AGIUS, MARK
STUDY OF SUBCUTANEOUS EVERY OTHER
DAY TREATMENT OF PATIENTS WITH
RELAPSING REMITTING MULTIPLE
SCLEROSIS WITH (PHASE A) DOUBLE BLIND
BETASERON/BETAFERON 250UG OR 500UG
OR OPEN LABEL BETASERON/BETAFERON
250UG AND (PHASE B) OPEN LABEL
BETASERON/BETAFERON 500UG
AGIUS, MARK
OPEN LABEL EXTENSION STUDY TO
EVALUATE THE SAFETY, TOLERABILITY AND
ACTIVITY OF ORAL FAMPRIDINE-SR IN
PATIENTS WITH MULTIPLE SCLEROSIS WHO
PARTICPATED IN THE MS-F204 TRIAL
ANDERSON, JENNIFER ALLELE SPECIFIC RNAI TREATMENT FOR
SLOW CHANNEL SYNDROME CAUSED BY M2
ACETYLCHOLINE RECEPTOR MUTATIONS
APPERSON, MICHELLE TRAINING IN CLINICAL TRIALS: ESSENTIAL
FOR A CAREER IN MULTIPLE SCLEROSIS RES
BATEMAN, LISA
A DOUBLE BLIND, RANDOMIZED, PLACEBO
CONTROLLED STUDY TO EVALUATE THE
SAFETY, TOLERABILITY AND EFFICACY OF
GANAXOLONE AS ADD-ON THERAPY IN
ADULT SUBJECTS WITH EPILEPSY
NEUROLOGY
DE CARLI, CHARLES
NEUROLOGY
DE CARLI, CHARLES
NEUROLOGY
DE CARLI, CHARLES
NEUROLOGY
DE CARLI, CHARLES
NEUROLOGY
NEUROLOGY
DE CARLI, CHARLES
DE CARLI, CHARLES
NEUROLOGY
DE CARLI, CHARLES
NEUROLOGY
DISBROW, ELIZABETH
NEUROLOGY
FAIRCLOUGH, ROBERT
NEUROLOGY
NEUROLOGY
FAIRCLOUGH, ROBERT
FARIAS, SARAH
NEUROLOGY
GORIN, FREDRIC
NEUROLOGY
LOSSIN, CHRISTOPHER
NEUROLOGY
MASELLI, RICARDO
NEUROLOGY
MASELLI, RICARDO
NEUROLOGY
MASELLI, RICARDO
NEUROLOGY
MASELLI, RICARDO
A PHASE II, MULTICENTER, OPEN LABEL,
LONG TERM TREATMENT STUDY TO
DETERMINE THE SAFETY, TOLERABILITY
AND EFFICACY OF AAB-001 (ELN115727) IN
PATIENTS WITH ALZHEIMER’S DISEASE
WHO PARTICIPATED IN STUDY AAB-001201, AAB-001-202 OR AAB-001-102
EPIDEMIOLOGY OF DEMENTIA IN THE
FRAMINGHAM STUDY
the aging brain: vasculature, ischemia and
behavior (CORE A)
EFFECTS OF DOCOSAHEXAENOIC ACID IN
SLOWING TGHE PROGRESSION OF
ALZHEIMER’S DISEASE
NAT’L ALZHEIMER’S COORDINATING CTR
A MULTICENTER, DOUBLE BLIND, PLACEBO
CONTROLLED THERAPEUTIC TRIAL TO
DETERMINE WHETHER NATURAL HUPERZINE
A IMPROVES COGNITIVE FUNCTION
ALZHEIMER’S DISEASE NEUROIMAGING
INITIATIVE
LINKING FUNCTIONAL IMAGING,
NEUROPHYSIOLOGY AND ANATOMY
HOW CONGENITAL MYASTHENIC SYNDROME
POINT MUTATIONS AFFECT ACHR
ASSEMBLY, FUNCTION AND SYNAPTIC
UC OF DAVIS ALLIANCE FELLOWS PROG
MEASUREMENT & PREDICTION OF EVERYDAY
FUNCTION DEMENTIA
NOVEL AMILORIDE CONJUGATES
SELECTIVELY KILL GILOMAS
RESCUE OF EPILEPSY ASSOCIATED
PREMATURE STOP CODONS WITH
CONGENITAL MYASTHENIC SYNDROMES:
EMERGING MODALITIES OF TREATMENT
EFFECT OF PYRIDOSTIGMINE ON THE
PHYSIOLOGIC AND MORPHOLOGIC
CHANGES INDUCED BY SOMAN AT THE
HUMAN NEUROMUSCULAR JUNCTION
CONGENITAL MYASTHENIC SYNDROMES:
REFINING NEWER TOOLS FOR DIAGNOSIS
AND TREATMENT
CONGENITAL MYSTHENIC SYNDROMES:
INNOVATIVE MODALITIES OF DIAGNOSIS
AND TREATMENT
NEUROLOGY
MUNGAS, DAN
NEUROLOGY
NEUROLOGY
NEUROLOGY
PLEASURE, DAVID
REED, BRUCE
REED, BRUCE
NEUROLOGY
RICHMAN, DAVID
NEUROLOGY
RICHMAN, DAVID
NEUROLOGY
NEUROLOGY
RICHMAN, DAVID
RICHMAN, DAVID
NEUROLOGY
NEUROLOGY
SHARP, FRANK
SHARP, FRANK
NEUROLOGY
NEUROLOGY
SHARP, FRANK
SHARP, FRANK
NEUROLOGY
SHARP, FRANK
NEUROLOGY
NEUROLOGY
SHARP, FRANK
WHEELOCK, VICKI
NEUROLOGY
WHEELOCK, VICKI
NEUROLOGY
ZHANG, LIN
NEUROLOGY
ZHANG, LIN
OBSTETRICS & GYNECOLOGY
DULEBA, ANTONI
OBSTETRICS & GYNECOLOGY
OBSTETRICS & GYNECOLOGY
TOWNER, DENA
WAETJEN, ELAINE
OBSTETRICS & GYNECOLOGY
YASMEEN, SHAGUFTA
OPHTHALMOLOGY
BRANDT, JAMES
the aging brain: vasculature, ischemia and
behavior (projECT 5)
EXCITOTOXICITY IN EAE
ALZHEIMER'S DISEASE RES CTR OF CALIF
the aging brain: vasculature, ischemia and
behavior (projECT 1)
ANIMAL MODELS OF MUSK ANTIBODY
ASSOCIATED MYASTHENIA GRAVIS
THYMECTOMY IN NON THYMOMATOUS MG
PATIENTS ON PREDNISONE
2007 CLINICAL RESEARCH AWARD
ANALYSIS OF NEWLY IDENTIFIED SPLICING
VARIANT OF MUSCLE SPECIFIC KINASE
HEMORRHAGE INDUCED BRAIN INJURY
BLOOD GENOMIC STUDIES OF CHILDREN
WITH IDIOPATHIC AUTISM
MARKERS OF CNS INJURY
ISCHEMIC STROKE AND INTRACEREBRAL
HEMORRAHAGE GENOMIC STUDIES IN
GENOMICS AND GENETICS OF TIAS AND
STROKE IN HUMANS
PARENTAL AUTISM SUSCEPTIBILITY TEST
A MULTICENTER, DOUBLE BLIND, PARALLEL
GROUP, PLACEBO CONTROLLED TRIAL OF
ETHYL-EPA (MIRAXION) IN PATIENTS WITH
MILD TO MODERATE HUNTINGTON’S
DISEASE (TREND-HD)
DIMEBON IN SUBJECTS WITH
HUNTINGTON’S DISEASE (DIMOND)
A RANDOMIZED, DOUBLE BLIND, ACTIVE
AND PLACEBO CONTROLLED EFFICACY
STUDY OF PRAMIPEXOLE GIVEN 0.5 MG AND
0.75 MG BID OVER A 12 WEEK TREATMENT
PHASE IN EARLY PARKINSON’S DISEASE
A LONGITUDINAL OBSERVATIONAL FOLLOWUP OF THE PRECEPT STUDY COHORT
MEVALONATE PATHWAY AND THECALINTERSTITIAL FUNCTION
CALIFORNIA PRENATAL SCREENING
MID-LIFE AGING AND URINARY
INCONTINENCE IN A MULTI-ETHNIC
COMORBIDITIES AND BREAST CANCER
AMONG ELDERLY WOMEN IN THE STATE OF
CALIFORNIA
ALLERGAN HORIZON GRANT PROG
OPHTHALMOLOGY
ISHIDA, ANDREW
OPHTHALMOLOGY
OPHTHALMOLOGY
OPHTHALMOLOGY
MANNIS, MARK
MANNIS, MARK
MORSE, LAWRENCE
OPHTHALMOLOGY
MORSE, LAWRENCE
OPHTHALMOLOGY
MORSE, LAWRENCE
OPHTHALMOLOGY
OPHTHALMOLOGY
MORSE, LAWRENCE
MORSE, LAWRENCE
OPHTHALMOLOGY
OPHTHALMOLOGY
O’HARA, MARY
PARK, SUSANNA
OPHTHALMOLOGY
PARK, SUSANNA
PHARMACOLOGY AND PHYSIOLOGY OF
RETINAL GANGLION CELLS
CORNEA DONOR STUDY
RPB UNRESTRICTED GRANT
AN EVALUATION OF EFFICACY AND SAFETY
OF POSTERIOR JUXTASCLERAL
ADMINISTRATIONS OF ANECORTAVE
ACETATE FOR DEPOT SUSPENSION (15MG
OR 30MG) VERSUS SHAM ADMINISTRATION
IN PATIENTS (ENROLLED IN STUDY "A" OR
STUDY "B") AT RISK FOR DEVELOPING
SIGHT-THREATENING CHOROIDAL
NEOVASCULARIZATION (CNV) DUE TO
EXUDATIVE AGE-RELATED MACULAR
a six month, phase III multicenter, masked
randomized, sham-controlled trial (with six
month open label extensioin) to assess the
safety and efficacy of 700 mg and 350 mg
dexamethasone posterior segment drug
delivery system in the treatment of patients
with macular edema following central retinal
vein occlusion of branch-vein occlusion
AN OPEN LABEL, MULTICENTER EXTENSION
STUDY TO EVALUATE THE SAFETY AND
TOLERABILITY OF RANIBIZUMAB IN
SUBJECTS WITH SUBFOVEAL CHOROIDAL
NEOVASCULARIZATION SECONDARY TO AGERELATED MACULAR DEGENERATION WHO
HAVE COMPLETED THE TREATMENT PHASE
OF A GENENTECH SPONSORED
RANIBIZUMAB STUDY (HORIZON FVF3426G)
AGE RELATED EYE DISEASE STUDY II
PROTOCOL B7A-MC-MBDV OPEN LABEL
TREATMENT FOR PATIENTS COMPLETING
STUDY B7A-MC-MBCM
PEDIATRIC EYE DISEASE INVESTIGATOR
A 3 YEAR, PHASE III, MULTICENTER,
MASKED, RANDOMIZED SHAM-CONTROLLED
TRIAL TO ASSESS THE SAFETY AND
EFFICACY OF 700UG DEXAMETHASONE
POSTERIOR SEGMENT DRUG DELIVERY
SYSTEM (DEX PS DDS) APPLICATOR SYSTEM
IN THE TREATMENT OF PATIENTS WITH
PHASE I PILOT OPEN LABEL PROSPECTIVE
OBSERVATIONAL STUDY OF SAFETY AND
OPHTHALMOLOGY
ROSENBLATT, MARK
OPHTHALMOLOGY
ROSENBLATT, MARK
OPHTHALMOLOGY
OPHTHALMOLOGY
ROSENBLATT, MARK
TELANDER, DAVID
OPHTHALMOLOGY
TELANDER, DAVID
OPHTHALMOLOGY
TELANDER, DAVID
OPHTHALMOLOGY
TELANDER, DAVID
OPHTHALMOLOGY
TELANDER, DAVID
OPHTHALMOLOGY
WERNER, JOHN
OPHTHALMOLOGY
OPHTHALMOLOGY
WERNER, JOHN
WERNER, JOHN
ORTHOPAEDIC SURGERY
DI CESARE, PAUL
EFFECTS AND RECEPTORS OF VASCULAR
ENDOTHELIAL GROWTH FACTOR ON
TRIGEMINAL SENSORY NEURONS
PREVENTION OF CORNEAL
NEOVASCULARIZATION IN VIVO
TRANSPLANTATION OF ENDOSTATIN
EXPRESSING CORNEAL EPITHELIAL CELLS
VIA SILK BIOMATRIX
CORNEAL WOUND HEALING ASSAYS
THE EFFECTS OF EMBRYONIC STEM CELLS
ON A MURINE MODEL OF RETINAL
A PHASE IV, OPEN LABEL, MULTICENTER
TRIAL OF MAINTENANCE INTRAVITREOUS
INJECTIONS OF MACUGEN (PEGAPTANIB
SODIUM) GIVEN EVERY 6 WEEKS FOR 48
WEEKS IN SUBJECTS WITH SUBFOVEAL
NEOVASCULAR AGE RELATED MACULAR
DEGENERATION (AMD) INITIALLY TREATED
WITH A MODALITY RESULTING IN
A RANDOMIZED, DOUBLE MASKED,
PARALLEL GROUP, MULTICENTER, DOSE
FINDING COMPARISON OF THE SAFETY AND
EFFICACY OF ASI-001A 0.5 UG/DAY AND ASI001A 0.2 UG/DAY FLUOCINOLONE
ACETONIDE INTRAVITREAL INSERTS TO
SHAM INJECTION IN SUBJECTS WITH
DIABETIC MACULAR EDEMA (FAME,
A PHASE II/III STUDY OF ENCAPSULATED
HUMAN NTC-201 CELL IMPLANTS
RELEASING CILIARY NEUROTROPHIC
FACTOR FOR PARTICIPANTS WITH
RETINITIS PIGMENTOSA USING VISUAL
FIELD SENSITIVITY AS THE PRIMARY
A PHASE II/III STUDY OF ENCAPSULATED
HUMAN NTC-201 CELL IMPLANTS
RELEASING CILIARY NEUROTROPHIC
FACTOR FOR PARTICIPANTS WITH
RETINITIS PIGMENTOSA USING VISUAL
ACUITY AS THE PRIMARY OUTCOME (CNTFOPTICAL AND NEURAL CHANGES IN THE
AGING VISUAL SYSTEM
TRAINING PROG IN VISION SCIENCE
OPHTHALMIC IMAGING USING ADAPTIVE
OPTICS AND OCT
A RANDOMIZED, DOUBLE BLIND, ACTIVE
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
ORTHOPAEDIC SURGERY
OTOLARYNGOLOGY
OTOLARYNGOLOGY
OTOLARYNGOLOGY
GENETOS, DAMIAN CHREFFECTS OF BIOPHOSPHONATES ON
OSTEOCYTE SCLEROSTIN RESPONSE TO
MECHANICAL STIMULATION
JAMALI, AMIR
RECAP TOTAL RESURFACING SYSTEM
CLINICAL STUDY
KHAN, SAFDAR
DOES SCREW ORIENTATION AFFECT
FIXATION STRENGTH IN VERFICAL SHEAR
FRACTURES OF THE MEDIAL MALLEOLUS?
LO, SU HAO
THE ROLE OF CTEN IN PROSTATE CANCER
LO, SU HAO
ROLE OF TENSIN GENES IN TISSUE
REGENERATION AND REPAIR
MARTIN, R. BRUCE
LONG TERM EFFECTS OF BISPHOSPHONATE
THERAPY ON BONE
MEEHAN, JOHN
EFFECTS OF JOINT REPLACEMENT ON
CARDIOVASCULAR FITNESS, DISEASE RISK
AND QUALITY OF LIFE
NATHE, TAYLOR
SURGICAL ANATOMY OF SUPRACLAVICULAR
NERVE OVER THE CLAVICLE
PATEL, RAVI
BIOMECHANICAL COMPARISON OF LARGE
FRAGMENT AND SMALL FRAGMENT LC DCP
PLATES IN THE FIXATION OF HUMERAL
SHAFT FRACTURES
REDDI, HARI
HESC AND ARTICULAR CARTILAGE
REGENERATION (SEED)
ROBERTO, ROLANDO
A BIOMECHANICAL STUDY OF REPAIR
TECHNIQUES FOR SPONDYLOLYTIC
VERTEBRAL FRACTURES
ROBERTO, ROLANDO
THE IMPACT OF INCREMENTAL POSTERIOR
BONY AND LIGAMENTOUS DECOMPRESSION
ON CERVICAL SPINE STABILITY FOLLOWING
DISC REPLACEMENT
YOU, ZONGBING
THE ROLE OF IL-17RL IN PROSTATE CANCER
SYKES, JONATHAN
A PHASE III RANDOMIZED, PLACEBO
CONTROLLED, MULTICENTER, DOUBLE
BLIND STUDY OF THE SAFETY AND
DURATION OF EFFICACY OF RELOXIN
(BOTULINUM TYPE A TOXIN) IN
CORRECTION OF MODERATE TO SEVERE
GLABELLAR LINES (AND INCLUDING A SUBSTUDY TO DETECT ANY TREATMENT
SYKES, JONATHAN
a phase iii multicenter, open-label extension
study to assess the long-term safety of
repeat administrations of reloxin in the
treatment of glabellar lines
TOLLEFSON, TRAVIS
RESTORATION OF EYELID CLOSURE IN
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PATHOLOGY & LABORATORY MEDICINE
PEDIATRICS
BARRY, PETER
A NON-HUMAN PRIMATE MODEL FOR
CYTOMEGALOVIRUS VACCINE
BARTHOLD, STEPHEN VETERINARY STUDENT RES TRAINING PROG
BOROWSKY, ALEXANDE UCD MOUSE BIOLOGY PROG: PATHOLOGY
RESOURCE, TRAINING AND CANCER
CHENG, HWAI-JONG
PLEXINS AND MOLECULAR MECHANISMS OF
AXON GUIDANCE
DASU, RAVI
MOLECULAR MECHANISMS OF TOLL
RECEPTOR ACTIVATION IN HYPERGLYCEMIA
DEVARAJ, SRIDEVI
CELLULAR PATHWAYS OF INFLAMMATION IN
TYPE 1 DIABETES
ELLIS, WILLIAM
the aging brain: vasculature, ischemia and
behavior (NEUROPATH CORE)
ESSER, URSULA
MONOCYTE BRAIN INFILTRATION IN ACUTE
SIV INFECTION
GREEN, RALPH
VITAMIN B6, VASCULAR DYSFUNCTION AND
ADHESION MARKERS IN SICKLE CELL
GREGG, JEFF
TARGETED CHEMOPREVENTION IN A MOUSE
MODEL FOR DCIS
GREGG, JEFF
CHEMOPREVENTION IN A MOUSE MODEL
FOR DCIS
HOGARTH, MICHAEL
CALIFORNIA ELECTRONIC DEATH REGISTRY
SYSTEM - TRAINING, MAINTENANCE AND
OPERATIONS (CA-EDRS)
HOGARTH, MICHAEL
BLUEPRINT FOR REGIONAL EXCELLENCE IN
BREAST CANCER CARE
JIALAL, ISHWARLAL
INFLAMMATION, CELLULAR DYSFUNCTION
AND METABOLIC SYNDROME
JIALAL, ISHWARLAL
MOLECULAR MECHANISMS OF TOLL
RECEPTOR ACTIVATION IN TYPE 1 DIABETES
JIALAL, ISHWARLAL
C-REACTIVE PROTEIN AND
JIALAL, ISHWARLAL
clinical studies in nutrition and metabolism
JIN, LEE-WAY
the use of novel amyloid binding ligands for
anti-amyloid therapies
RAPID MULTIPATHOGEN DETECTION FOR
KOST, GERALD
POCT AND NATIONAL DISASTER READINESS
LUCIW, PAUL
MULTIPLEX IMMUNOASSAYS FOR THE
DETECTION OF TUBERCULOSIS
MILLER, JOSHUA
FOLATE, DNA METHYLATION AND BREAST
TUMORIGENESIS
MILLER, JOSHUA
FOLATE AND DNA METHYLATION IN A
MOUSE MODEL OF BREAST CANCER
SINGH, UMA
C-REACTIVE PROTEIN AND LEUKOCYTE
DERIVED MYELOPEROXIDASE
BLUMBERG, DEAN
A PHASE III RANDOMIZED, MULTINATIONAL
PEDIATRICS
BUTANI, LAVJAY
PEDIATRICS
PEDIATRICS
CHANTRY, CAROLINE
CHANTRY, CAROLINE
PEDIATRICS
CHANTRY, CAROLINE
PEDIATRICS
DUCORE, JONATHAN
PEDIATRICS
GLASER, NICOLE
PEDIATRICS
PEDIATRICS
glaser, nicole
HAGERMAN, RANDI
PEDIATRICS
HAGERMAN, RANDI
PEDIATRICS
PEDIATRICS
HAGERMAN, RANDI
HAGERMAN, RANDI
PEDIATRICS
HANSEN, ROBIN
PEDIATRICS
HANSEN, ROBIN
PEDIATRICS
HANSEN, ROBIN
PEDIATRICS
KON, ALEXANDER
PEDIATRICS
LI, SU-TING
PEDIATRICS
MAKKER, SUDESH
PEDIATRICS
MARCIN, JAMES
PEDIATRICS
MARCIN, JAMES
NAT’L COOPERATIVE GROWTH STUDY OF
NUTROPIN AQ, NUTROPIN AND NUTROPIN
DEPOT IN CHILDREN WITH GROWTH
FAILURE DUE TO CHRONIC RENAL
INSUFFICIENCY OR END STAGE RENAL
COMMUNITY LACTATION ASSISTANCE PROJ
FEASIBILITY AND PILOT EFFICACY OF FLASH
HEATED BREAST MILK FOR REDUCTION OF
MATERNAL TO CHILD TRANSMISSION OF
HIV IN TANZANIA
FEASIBILITY AND PILOT EFFICACY OF FLASH
HEATED BREAST MILK TO REDUCE
PEDIATRIC HIV
CASES FOR MOLECULAR EPIDEMIOLOGY OF
CHILDHOOD LEUKEMIA
TRIALNET NATURAL HISTORY STUDY OF THE
DEVELOPMENT OF TYPE 1 DIABETES
CEREBRAL EDEMA IN PEDIATRIC
GENOTYPE-PHENOTYPE RELATIONSHIPS IN
FRAGILE X FAMILIES
GENOTYPE-PHENOTYPE RELATIONSHIPS IN
FRAGILE X FAMILIES
FRAGILE X RESEARCH CTR AT UC DAVIS
CHARACTERIZATION AND TREATMENT OF
CNS ABNORMALITIES IN PREMUTATION
CARRIERS (HAGERMAN 4 OF 6)
SAFE SCHOOLS, HEALTHLY STUDENTS
VILLAGE PROJ INITIATIVE
UNIVERSITY CTR FOR EXCELLENCE IN
DEVELOPMENTAL DISABILITIES,
EDUCATION, RES AND SERVICE
FELLOWSHIP PROG IN DEVELOPMENTAL
DISABILITIES WITH AN EMPHASIS ON
NEURODEVELOPMENTAL DISORDERS
INFORMED CONSENT IN RESEARCH
INVOLVING CHILDREN
IMPROVING ORAL PRESENTATION SKILLS IN
PEDIATRIC MEDICAL STUDENTS USING A
WEB BASED PRESENTATION MODULE
MEMBRANOUS NEPHRITIS ANTIGEN
DEFINED BY PHAGE ANTIBODIES
IMPROVING THE CARE OF ACUTELY ILL AND
INJURED CHILDREN IN RURAL EMERGENCY
DEPARTMENTS WITH TELEMEDICINE
INCREASING ACCESS AND IMPROVING THE
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
PEDIATRICS
MILLER, ELIZABETH
AN ETHNOGRAPHIC STUDY OF ADOLESCENT
DATING VIOLENCE: DEVELOPMENTAL AND
CULTURAL CONSIDERATIONS
MILLER, ELIZABETH
ASSESSING THE HEALTH IMPACT OF
TRADITIONAL ARTS PROG ON
UNDERSERVED MINORITY COMMUNITIES
MILLER, ELIZABETH
ASSESSING THE HEALTH IMPACT OF
TRADITONAL ARTS PROGRAMS ON
UNDERSERVED MINORITY COMMUNITIES
NATALE, JOANNA
AGE DEPENDENT MOLECULAR RESPONSES
TO BRIAN INJURY
PAN, RICHARD
COMMUNITY PARTNERSHIPS WITH
PEDIATRICIANS FOR HEALTHY CHILDREN
PETERSON, MARILYN
CHILD SEXUAL ABUSE EXAM MENTORING
PETERSON, MARILYN
CHILD SEXUAL ABUSE TREATMENT PROG
PETERSON, MARILYN
child abuse treatment program (chat)
PETERSON, MARILYN
CALIFORNIA MEDICAL TRAINING CTR
ROGERS, KRISTEN
CALIF DRUG ENDANGERED CHILDREN’S
MULTIDISCIPLINARY DATABASE
STYNE, DENNIS
PLANNING PROG, ROUND VALLEY TRIBAL
HEALTH AND FEATHER RIVER INDIAN
STYNE, DENNIS
FUNDAMENTAL AND SOCIAL CHANGE FOR
DIABETES PREVENTION IN NATIVE INDIAN/
ALASKA NATIVE COMMUNITIES proj
TARANTAL, ALICE
ANNUAL GENE THERAPY SYMPOSIUM FOR
LUNG AND BLOOD DISEASES
TARANTAL, ALICE
UC DAVIS TRANSLATIONAL HUMAN
EMBRYONIC STEM CELL SHARED RES
TARANTAL, ALICE
CTR FOR FETAL MONKEY GENE TRANSFER
FOR HEART, LUNG AND BLOOD DISEASES
TARANTAL, ALICE
CTR FOR PEDIATRIC STEM/PROGENITOR
CELL RES
TRAMONTANO, ALFONSOIMMUNOTHERAPY FOR DIABETIC
COMPLICATIONS OF ADVANCED GLYCATION
WARDEN, CRAIG
FATTY ACID RESPONSES TO A LOW
CARBOHYDRATE DIET IN MICE WITH
KNOCKOUTS FOR MILOCHONDRIAL UCP2
AND UCP3
WARDEN, CRAIG
RAPID ISOLATION OF DIET-RESPONSIVE
OBESITY GENES
WARDEN, CRAIG
POSITIONAL CLONING OF OBESITY GENES
FROM CONGENIC MICE
CIGARETTE SMOKE ULTRAFINE PARTICLE
WIEDEMAN, JEAN
EXPOSURE, CHLAMYDIA PNEUMONIAE AND
ATHEROSCLEROSIS
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PHYSIOLOGY & MEMBRANE BIOLOGY
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
BORODINSKY, LAURA
ACTIVITY DEPENDENT REGULATION OF
EARLY STAGES IN SYNAPSE FORMATION
CURRY, FITZ-ROY
NEW APPROACH TO ENDOTHELIAL CLEFT
STRUCTURE
CURRY, FITZ-ROY
TRANSPORT ACROSS CAPILLARY
FERNS, MICHAEL
regulation of the synaptic localization of the
nachr
FOMINA, ALLA
SUBCELLULAR LOCALIZATION AND
FUNCTIONS OF PHOSPHATIDYLSERINE
RECEPTOR DURING MACROPHAGE
LIN, YU-FUNG
FACULTY RES GRANT
MECHANISM OF ION CHANNEL MODULATION
NIMIGEAN, CRINA
BY LIGANDS
NIMIGEAN, CRINA
MECHANISM OF ION CHANNEL MODULATION
BY LIGANDS
O’DONNELL, MARTHA BLOOD-BRAIN BARRIER IN CEREBRAL
O’DONNELL, MARTHA BLOOD BRAIN BARRIER ION TRANSPORT IN
CEREBRAL ISCHEMIA (SHANNON AWARD)
PAYNE, JOHN
K-C1 COTRANSPORTERS IN RAT NERVOUS
SYSTEM
TRIMMER, JAMES
NINDS/ UC DAVIS NEUROMAB HYBRIDOMA
FACILITY
TRIMMER, JAMES
K+ CHANNEL ALPHA AND BETA SUBUNIT
INTERACTIONS
TRIMMER, JAMES
NINDS/ UC DAVIS NEUROMAB HYBRIDOMA
FACILITY
TRIMMER, JAMES
DETERMINANTS OF DENDRITIC POTASSIUM
CHANNEL LOCALIZATION
WIDDICOMBE, JONATHACFTR VS. CA-ACTIVATED CHLORIDE
CHANNELS IN AIRWAY GLANDS
ZHENG, JIE
REGULATION OF TRPV1 CHANNEL ACTIVITY
BY PROTON, LIGANDS AND CALMODULIN
ZHENG, JIE
THE ACTIVATION GATE OF CYCLIC
NUCLEOTIDE GATED CHANNELS
AMARAL, DAVID
evaluation of face processing with
psychophysiological and eeg indices of
negative affect in children with autism or
behavioral inhibition
AMARAL, DAVID
FUNCTIONAL ORGANIZATION OF THE
HIPPOCAMPAL FORMATION
AMARAL, DAVID
NON-HUMAN PRIMATE AUTISM MODEL
BASED ON MATERNAL INFECTION
AMARAL, DAVID
NEUROBIOLOGY OF SOCIAL BEHAVIOR
AMARAL, DAVID
ANATOMY OF THE PRIMATE AMYGDALOID
COMPLEX
PSYCHIATRY & BEHAVIORAL SCIENCES
CARTER, CAMERON
PSYCHIATRY & BEHAVIORAL SCIENCES
CARTER, CAMERON
PSYCHIATRY & BEHAVIORAL SCIENCES
CARTER, CAMERON
PSYCHIATRY & BEHAVIORAL SCIENCES
carter, cameron
PSYCHIATRY & BEHAVIORAL SCIENCES
CARTER, CAMERON
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
CHIU, SUFEN
CORBETT, BLYTHE
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
CORBETT, BLYTHE
FEINBERG, IRWIN
PSYCHIATRY & BEHAVIORAL SCIENCES
HENDREN, ROBERT
PSYCHIATRY & BEHAVIORAL SCIENCES
HENDREN, ROBERT
PSYCHIATRY & BEHAVIORAL SCIENCES
HENDREN, ROBERT
PSYCHIATRY & BEHAVIORAL SCIENCES
HENDREN, ROBERT
PSYCHIATRY & BEHAVIORAL SCIENCES
HENDREN, ROBERT
brain based measures for treatment
development of impaired cognition in
schizophrenia
MECHANISMS OF CONTEXT PROCESSING IN
SCHIZOPHRENIA
INTERDISCIPLINARY TRAINING PROG IN
NEUROTHERAPEUTICS (HAGERMAN 6 OF 6)
CORTICAL CIRCUITRY AND COGNITION IN
SCHIZOPHRENIA
COGNITIVE NEUROGENETICS OF
SCHIZOPHRENIA
PEDIATRIC PSYCHOSIS AND
NEURAL UNDERPINNINGS OF DEFICIENT
COGNITIVE CONTROL IN DEVELOPMENTAL
DISORDERS AFFECTING FRONTOSTRIATAL
CIRCUITRY
THE ROLE OF THE AMYGDALA IN AUTISM
LONGITUDINAL MEASUREMENTS OF SLEEP
EEG IN ADOLESCENCE
FELLOWSHIP PROG IN CHILD AND
ADOLESCENT PSYCHIATRY AT UC DAVIS
A 6 WEEK INTERNATIONAL, MULTICENTER,
RANDOMIZED, DOUBLE BLIND, PARALLEL
GROUP, PLACEBO CONTROLLED PHASE IIIB
STUDY OF THE EFFICACY AND SAFETY OF
QUETIAPINE FUMARATE (SEROQUEL)
IMMEDIATE RELEASE TABLETS IN DAILY
DOSES OF 400 MG AND 800 MG COMPARED
WITH PLACEBO IN THE TREATMENT OF
CHILDREN AND ADOLESCENTS WITH
A 26 WEEK INTERNATIONAL, MULTICENTER,
OPEN LABEL PHASE IIIB STUDY OF THE
SAFETY AND TOLERABILITY OF QUETIAPINE
FUMARATE (SEROQUEL) IMMEDIATE
RELEASE TABLETS IN DAILY DOSES OF 400
MG AND 800 MG IN CHILDREN WITH
BIPOLAR I DISORDER AND ADOLESCENTS
A 52 WEEK OPEN LABEL, MULTICENTER
STUDY OF THE SAFETY AND TOLERABILITY
OF ARIPIPRAZOLE FLEXIBLY DOSED IN THE
TREATMENT OF CHILDREN AND
ADOLESCENTS WITH AUTISTIC DISORDER
A MULTICENTER, DOUBLE BLIND,
RANDOMIZED PLACEBO CONTROLLED
PARalLel GROUP STUDY WITH THREE FIXED
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
PSYCHIATRY & BEHAVIORAL SCIENCES
MADDOCK, RICHARD
A 52 WEEK, RANDOMIZED, DOUBLE BLIND,
PLACEBO CONTROLLED, MULTICENTER,
PARALLEL GROUP STUDY OF THE LONG
TERM EFFICACY, TOLERABILITYAND SAFETY
OF AGOMELATINE 25 AND 50 MG IN THE
PREVENTION OF RELAPSE OF MAJOR
DEPRESSIVE DISORDER FOLLOWING OPEN
LABEL TREATMENT OF 16-24 WEEKS
OZONOFF, SALLY
infants at risk of autism: a longitudinal
OZONOFF, SALLY
a california population-based twin study of
autism
ROGERS, SALLY
GAZE PATTERNS IN AUTISM ACROSS THE
FIRST TWO YEARS OF LIFE
ROGERS, SALLY
inTernational mtg for autism res
ROGERS, SALLY
A MULTI SITE RANDOMIZED STUDY OF
INTENSIVE TREATMENT FOR TODDLERS
WITH AUTISM
ROGERS, SALLY
INTERVENTION FOR INFANTS AT HIGH RISK
FOR AUTISM
ROGERS, SALLY
INTERDISCIPLINARY TRAINING FOR AUTISM
RESEARCHERS
ROGERS, SALLY
WORKSHOP ON NEUROCOGNITIVE
DEVELOPMENT AND AUTISM: “THE MIRROR
NEURON HYPOTHESIS”
SALO, RUTH
COGNITIVE SEQUELAE OF
METHAMPHETAMINE ABUSE
SALO, RUTH
NEURAL CORRELATES OF
METHAMPHETAMINE USE IN
SCHWEITZER, JULIE
A COMPENSATORY FUNCTIONAL
NEUROANATOMY OF ADHD
SIMON, TONY
VISUOSPATIAL COGNITIVE DEFICIT IN
DEL22Q11.2 SYNDROME
SIMON, TONY
NUMERICAL DEFICITS ACROSS MULTIPLE
GENETIC DISORDERS
SIMON, TONY
FRAGILE X SPECTRUM AS A MODEL TO
EXPLORE NEUROGENETIC MECHANISMS OF
COGNITIVE DYSFUNCTION (HAGERMAN 5 OF
SOLOMON-FRIEDMAN, MCOGNITIVE CONTROL IN AUTISM
SOLOMON-FRIEDMAN, MMOTIVATION AND COGNITIVE CONTROL IN
AUTISM
URSU, STEFAN
THE RELATIONSHIP BETWEEN REWARD
PROCESSING, ORBITOFRONTAL CORTEX
DYSFUNCTION AND NEGATIVE SYMPTOMS
IN UNMEDICATED SCHIZOPHRENIA
PATIENTS: A FUNCTION MRI EXPLORATION
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
PUBLIC HEALTH SCIENCES
RADIATION ONCOLOGY
RADIATION ONCOLOGY
RADIATION ONCOLOGY
RADIATION ONCOLOGY
RADIOLOGY
RADIOLOGY
RADIOLOGY
RADIOLOGY
BUTLER, LESLEY
ACCULTURATION AND GASTRIC CANCER
AMONG HISPANICS
CASSADY, DIANA
TOBACCO CONTROL EVAL CTR
CASSADY, DIANA
HEAL PROJ
GOLD, ELLEN
STUDY OF WOMEN’S HEALTH ACROSS THE
NATION III
GOLD, ELLEN
SWAN SLEEP STUDY II-UC DAVIS/ KAISER
HERTZ-PICCIOTTO, IRVAMETHODS DEVELOPMENT FOR EXPOSURE
RELATED BEHAVIORS
HERTZ-PICCIOTTO, IRVATHE CHARGE STUDY: CHILDHOOD AUTISM
RISKS FROM GENETICS AND THE
HERTZ-PICCIOTTO, IRVAPCBS AND OTODEVELOPMENT IN EASTERN
SLOVAKIA
HERTZ-PICCIOTTO, IRVANORTHERN CALIF CHILDREN’S STUDY
CONSORTIUM
LEIGH, PAUL
costs of occupational injury and illness
LEISTIKOW, BRUCE
WORKER’S COMPENSATION REVIEW
GUIDELINE DEVELOPMENT
MC CURDY, STEPHEN
PESTICIDE RELATED ILLNESS DATA
EXCHANGE PROJ
ROCKE, DAVID
ISMB 2007 CONFERENCE: SUPPORT FOR
STUDENT AND YOUNG SCIENTISTS
ROCKE, DAVID
METHODS FOR ANALYSIS OF HIGH
THROUGHPUT ASSAY DATA
ROCKE, DAVID
GENOMEWIDE EVAL OF NORMAL HUMAN
TISSUE IN RESPONSE TO CONTROLLED, IN
VIVO LOW DOSE LOW LET IONIZING
RADIATION EXPOSURE: PATHWAYS AND
MECHANISMS
SCHENKER, MARC
CALIFORNIA CANCER RES PROG
SCHENKER, MARC
AGRICULTURAL HEALTH AND SAFETY
CENTER AT UC DAVIS
VAUGHAN, ANDREW
JOINT RADIATION BIOMARKER RES
VAUGHAN, ANDREW
MECHANISM OF RADIATION SENSITIZATION
OF SAHA (VORINOSTAT)
VAUGHAN, ANDREW
A MULTICENTER, DOUBLE BLIND, PLACEBO
CONTROLLED THERAPEUTIC TRIAL TO
DETERMINE WHETHER NATURAL HUPERZINE
A IMPROVES COGNITIVE FUNCTION
VAUGhAN, ANDREW
ADVANCED TECHNOLOGY QA CTR
BADAWI, RAMSEY
TUMOR METRICS IN CANCER THERAPEUTICS
BOONE, JOHN
NONDESTRUCTIVE CHARACTERIZATION
BOONE, JOHN
BREAST CT SCANNER FOR EARLIER cancer
DETECTION
BUONOCORE, MICHAEL NEUROBEHAVIORAL RELATIONS IN
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
SURGERY
UROLOGY
UROLOGY
UROLOGY
UROLOGY
ALI, MOHAMED
technique and patient outcomes in
laparoscopic gastric bypass
BOLD, RICHARD
A NOVEL THERAPY FOR PANCREAS AND
PROSTATE CANCER
BOLD, RICHARD
TARGETING AKT AS A NOVEL THERAPY IN
PANCREATIC CANCER
CHO, KIHO
ENDOGENOUS RETROVIRUSES AND GENE
REGULATION AFTER INJURY
DAWSON, DAVID
THE PIVITOL STUDY
DAWSON, DAVID
A PHASE II, RANDOMIZED, DOUBLE BLIND,
PLACEBO CONTROLLED, PARALLEL GROUP,
MULTICENTER, DOSE SELECTION STUDY OF
AD2/HYPOXIA INDUCIBLE FACTOR (HIF)1A/VP16 IN PATIENTS WITH INTERMITTENT
CLAUDICATION
DAWSON, DAVID
EVAL OF FM220 IN PATIENTS WITH
PERIPHERAL ARTERIAL DISEASE
DAWSON, DAVID
PLAQUE REMOVAL VS. OPEN BYPASS FOR
CRITICAL LIMB ISCHEMIA
LEE, EUGENE
REAL TIME VLS DETECTION OF COLON
ISCHEMIA IN AAA REPAIRS
UTTER, GARTH
MECHANISMS AND CLINICAL EFFECTS OF
TRANSFUSION ASSOCIATED
WOODS, ROXANNA
SACRAMENTO TRAUMA CTR ALCOHOL
INTERVENTION PROJ
WOODS, ROXANNA
A MULTI-FACETED BOOSTER SEAT EDUC
PROG FOR HEALTH SYSTEMS AND
WU, MACK
VEGF REGULATION OF MICROVASCULAR
PERMEABILITY
YUAN, SARAH
MICROVASCULAR BARRIER DYSFUNCTION
IN THERMAL TRAUMA
YUAN, SARAH
NEUTROPHIL DEPENDENT REGULATION OF
VENULAR PERMEABILITY
YUAN, SARAH
PKC ISOENZYMES AND DIABETIC
MICROVASCULAR HYPERPERMEABILITY
DE VERE WHITE, RALPH A SEQUENTIAL APPROACH TO THE
TREATMENT OF MUSCLE INVASIVE, NONMETASTATIC CARCINOMA OF THE BLADDER:
A PHASE II TRIAL OF NEOADJUVANT
GEMCITABINE, PACLITAXEL AND
CARBOPLATIN WITH MOLECULAR
DE VERE WHITE, RALPH har alterations and androgen-independant
prostate cancer
DE VERE WHITE, RALPH CANCER CTR SUPPORT GRANT
DE VERE WHITE, RALPH CANCER CTR SUPPORT GRANT - CURE